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ABSTRACT 
MICHAEL D. L. JOHNSON: The Effect of Calcium Binding on Adhesion and Pilus 
Biogenesis in the PilC Family of Proteins 
 (Under the direction of Matthew Redinbo) 
 
Pseudomonas aeruginosa is an opportunistic pathogen prevalent in people on 
immunosuppressants, recent open wounds, or cystic fibrosis patients. P. aeruginosa 
attaches to the host cell via polar type IV pili (tfp). These tfp are composed of many proteins 
including the major pilus subunit PilA, retraction protein PilT, and one focus of this 
dissertation, 1163 residue protein PilY1. PilY1 shares homology to other bacterial adhesion 
and pilus biogenesis proteins such as the PilC family of proteins in Neisseria gonorrhoeae, 
Neisseria meningitidis, and Kingella kingae thus, it is often characterized as a pilus 
biogenesis protein and the P. aeruginosa adhesin. However, no known mechanism for 
either situation had been elucidated. In this study, we have identified two calcium binding 
sites which affect both functional pilus biogenesis and adhesion to host cells. In addition, we 
have also located an RGD (integrin binding motif) that mediates PilY1 binding to integrin. 
The C-terminal most PilY1 calcium binding site (CBS) was found from residues 851-
859 in PAK and is conserved in other strains of P. aeruginosa. This CBS is also conserved 
in the PilC proteins over 100 different bacteria. We found, through mutating the bidentate 
aspartic acid in vitro and in vivo, that this CBS controlled functional pilus biogenesis with the 
calcium bound and unbound states corresponding to pilus extension and retraction 
respectfully. We also characterized the homologous CBSs in N. gonorrhoeae and K. kingae 
finding similar results. 
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Upon further examination, we also located separate CBS from residues 600-608. 
This site was in close proximity to an RGD. This CBS was conserved in other strains of P. 
aeruginosa, but not in other bacteria. We found that purified PilY1 bound integrin in an RGD 
dependent manner. Furthermore, we found that this interaction was mediated by the calcium 
bound states of both CBSs. 
Here, we demonstrate that P. aeruginosa PilY1 uses calcium to mediate both 
functional pilus biogenesis factor and adhesion to host cells. Future studies will hopefully 
include exploiting both calcium binding domains to prevent pilus formation and binding to 
host cells and characterizing the in vivo effects of these three sites.  
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Chapter 1 
Introduction to Pseudomonas aeruginosa Type IV Pili 
  
1.1 Pseudomonas aeruginosa Overview 
Pseudomonas aeruginosa is a rod-shaped Gram-negative opportunistic pathogen 
that is highly prevalent in people with cystic fibrosis, on immunosuppressants, or with recent 
open wounds or burns. Needing only minimal nutrients to live, P. aeruginosa has been 
found living on or in a variety of environments, including steel, soil, deionized distilled water, 
and gasoline [1,2]. Having the ability to undergo both aerobic and anaerobic respiration, this 
nosocomial pathogen has the ability to infect any part of the body; however infections 
typically occur in the respiratory system, broken skin, blood, or urinary tract [3]. Hospital 
acquired infections, which killed an estimated 100,000 people in 2002, infected an estimated 
1.7 million people in the U.S.; P. aeruginosa accounting for about 11% of those infections 
[4,5]. In addition to humans, this pathogen can infect other organisms, such as plants, 
insects, and other members of the animal kingdom, making it a bacterium of interest with 
significant relevance for studying the general mechanisms regulating pathogenesis [6,7].  
P. aeruginosa is resistant to many antibiotics, such as β-lactams, macrolides, 
tetracyclines, co-trimoxazole, and most fluoroquinolones; it further has the ability to develop 
resistance to many more antibiotics including penicillins, monobactams, and the remaining 
fluoroquinolones [8]. This bacterium evades antibiotics by using a variety of mechanisms.  
P. aeruginosa has a thick cell wall that makes it difficult for antibiotics to get through the 
membrane, it ejects antibiotics using efflux pumps, and it attenuates antibiotic effects by 
forming a protective biofilm [9,10,11]. P. aeruginosa can also evade antibiotic treatments 
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targeting vital bacterial pathways through an SOS response, a process where the organism 
purposely mutates its genes in an attempt to adapt to and thus overcome stress [12].  
 
1.2 P. aeruginosa Infection 
P. aeruginosa causes infection via multiple stepwise actions: first, using flagella, it 
swims to approach its target; second, it adheres to the surface of the target using arm-like 
protrusions called type IV pili (tfp) that are also responsible for “walking” on the surface, a 
process known as twitching motility; third, it undergoes quorum sensing (ability to detect 
other bacteria) and forms a protective alginate biofilm; and fourth, somewhat concurrently 
with the third step, it begins secreting virulence factors such as LasA and LasB elastase, 
exotoxin A, and alkaline protease [13,14,15,16,17]. Finally, individual bacterium can 
separate from the parent colony to cause infections in other host sites. A critical step in 
causing virulence is the tfp’s ability to attach to cells, tissues, or other surfaces, thereby 
allowing biofilm formation [2,13,18]. Without tfp, and hence the ability to anchor to a surface, 
P. aeruginosa cannot congregate to form a functional biofilm for its own protection and thus 
facilitate host infection [14].  
  
1.3 Type IV Pili  
 P. aeruginosa tfp typically extend from one end of the rod-shaped bacterial cell. Pili 
give the bacteria the ability to travel in two different ways. One method, which is more 
directional is where the pili pull or drag the bacteria on the long edge, while the other 
method, which leads to more random movement, is walking upright, or on the tip of the rod-
shaped bacteria [19]. Through twitching motility mediated pilus extension and retraction, tfp 
allow P. aeruginosa to move at speeds of 1 µm s−1 in a process that assembles and 
disassembles approximately 1,500 pilus subunits s−1 [20]. This process is ATP-dependent 
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and occurs during directed movement toward a nutritional gradient [21]. As can be 
expected, lack of tfp eliminates P. aeruginosa’s pathogenesis to host organisms due to lack 
of motility [15,18,22]. 
  
1.4 Proteins in the Type IV Pilus  
 There are more than forty proteins involved in the tfp. These proteins include PilA as 
the major pilin subunit; PilQ as the membrane pore protein through which the pilus extends 
and retracts; PilT, a key component in pilus retraction; PilB, which is responsible for pilus 
extension, and PilD, which is responsible for cleaving the membrane leader sequence on 
the pilus proteins [15,20,23,24]. There are also a number of pseudopilins (pilin-like proteins) 
that are incorporated into the main pilus fiber [25]. These proteins include FimU, PilV, PilW, 
PilX, and PilE, which are all located in the PilY1 operon controlled by AlgR [26,27]. Other 
members of this operon are PilY1 and PilY2 [26]. 
 P. aeruginosa tfp are long fibers containing polymerized PilA. Although the 
sequences can be quite divergent between strains, the consensus monomer structure 
(based on solved crystal structures) contains a long α-helix with a head group of four β-
strands, similar to the homologous protein PilE in Neisseria gonorrhoeae [28,29,30,31]. PilA 
is often thought to function as an adhesin in P. aeruginosa [28,32]. C-terminal disulfide-
connected loops may control binding at the tip of the pilus to gangliosides GM1 and GM2; 
however, this evidence has been disputed because it is not consistent throughout the 
bacterial strains [28,32,33,34,35]. 
 The current opinion on how these subunits polymerize is that, post PilD-mediated 
cleavage, PilA monomers are held in place in the membrane with the long α-helix tail 
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embedded in the membrane and the β-sheet head group sticking out, extracted using 
approximately three ATP molecules, and attached via electrostatic interactions using a 
conserved negatively charged glutamic acid of one PilA subunit attaching to the positively 
charged N-terminal region of another monomer [36,37,38,39]. The resultant polymer can be 
6-9 nm wide and up to 1-4 µm long [36]. It has been estimated that six ATP molecules are 
used to assemble a pilus subunit and it is possible that the other three are needed for the 
polymerization step [40]. Accordingly, pilus polymerization is regulated by the tfp elongation 
ATPase, PilB [41,42]. Mutations to the His box, Walker-A, or –B motifs eliminate surface 
piliation, twitching motility, and the pilus dependent process of phage susceptibility [43]. 
Functional tfp extension and retraction occurs through a pore made by a 
dodecameric protein, PilQ, as observed in Nesseria meningitidis [44,45]. PilQ is also thought 
to play a role in pilus assembly because of its conformational change upon tfp engagement 
and its association with only one end of the pilus fiber [46]. The necessary process of P. 
aeruginosa PilQ multimerization and insertion into the bacterial membrane is regulated by 
PilF [47]. PilF has been found to attach to the outer membrane of P. aeruginosa and control 
PilQ pore assembly through six tetratricopeptide repeat (TPR) protein-protein interaction 
motifs [47]. TPRs are helical structures usually involved in large protein complex formation 
[48]. 
Pilus retraction occurs though ATPases PilT and PilU [41,42,49,50,51]. Consistent 
with what is seen in PilB and N. gonorrhoeae, mutations to the ATP binding domains in both 
of these proteins in P. aeruginosa eliminate functional pilus biogenesis, twitching motility, 
and results in phage resistance [43,50,52]. The retraction power of PilT can generate forces 
of more than 100pN per fiber [53]. The apo and ATP bound crystal structures of P. 
aeruginosa PilT have been solved and reveals a homohexamer [51]. It is also thought that 
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PilT works in concert with P. aeruginosa PilC, N, O, and P to coordinate individual pilus 
subunit depolymerization via a “paddle-wheel” type mechanism [51].  
 
1.5 The fimUpilVWXY1Y2E Operon 
 The fimUpilVWXY1Y2E operon constitutes gene products for factors that fit into 
three families: pseudopilins/ minor pilin/ pilin-like protein family (FimU, PilV, W, X, and E), an 
uncharacterized group (PilY2), or the PilC family of proteins from the Neisseria family (PilY1) 
[26]. FimU, PilV, W, X, and E have been found to be necessary for functional pilus 
biogenesis and are integrated into the pilus [25].  All of these proteins share high homology 
to PilA with some minor differences. For example, PilW has a large predicted loop region 
within the head group of the protein. Integrated tfp minor pilins make a cuff in 1:1 
stoichiometric ratios at various parts of the pilus fiber [25]. It is possible that these cuffs 
provide the grip for PilT-mediated retraction. PilY2 shows no known homology to other 
proteins, and PilY2 deletion mutants exhibit reduced twitching motility and pilus biogenesis 
[26].  
 
1.6 PilY1 
Another protein involved in the tfp is an 1163 amino acid (PAK strain) protein called 
PilY1. PilY1, which contains a 30 amino acid leader sec-dependent periplasmic signal 
sequence that is cleaved by PilD, is found in the pilus and outer membrane of P. aeruginosa 
[15,26,54,55]. Targeting PilY1 to the periplasm also helps facilitate disulfide formation in the 
reducing environment. PilY1 is a P. aeruginosa pilus protein necessary for functional pilus 
biogenesis [26]. PilY1 has also been characterized as the P. aeruginosa adhesin; however, 
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there have been no previous reports of the attachment mechanism directly involving PilY1 
[15].  
PilY1 is a member of the PilC class of proteins found in organisms such as N. 
gonorrhoeae, N. meningitides, and Kingella kingae. PilC proteins have been characterized 
as both tfp biogenesis proteins and as the adhesins of their respective organisms; however, 
the evidence for these respective host cell receptors is not concrete [56,57,58]. Typically, 
the N-terminal regions of PilC are characterized as the adhesion domains, while the C-
terminal regions are known to be tfp biogenesis domains. PilY1 shares sequence homology 
with the C-terminal region of the PilC proteins but no N-terminal homology to any of proteins 
in this family. The lack of PilY1 N-terminal homology is consistent in that all of these 
organisms have different mechanisms for infection, and therefore, most likely have differing 
host target proteins. Investigating the role of these similar proteins may lead to broad-
spectrum treatments. It is the goal of this dissertation to further characterize the PilC family 
of proteins to obtain new information about their role in pilus biogenesis and adhesion. 
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2.1 SUMMARY 
 
Several bacterial pathogens require the “twitching” motility produced by filamentous 
type IV pili (T4P) to establish and maintain human infections. Two cytoplasmic ATPases 
function as an oscillatory motor that powers twitching motility via cycles of pilus extension 
and retraction. The regulation of this motor, however, has remained a mystery.  We present 
the 2.1 Å resolution crystal structure of the Pseudomonas aeruginosa pilus-biogenesis factor 
PilY1, and identify a single site on this protein required for bacterial translocation. The 
structure reveals a modified β-propeller fold and a distinct EF-hand calcium-binding site 
conserved in pathogens with retractile T4P.  We show that preventing calcium binding by 
PilY1 using either an exogenous calcium chelator or mutation of a single residue disrupts 
Pseudomonas twitching motility by eliminating surface pili. In contrast, placing a lysine in this 
site to mimic the charge of a bound calcium interferes with motility in the opposite manner – 
by producing an abundance of non-functional surface pili. Our data indicate that calcium 
binding and release by the unique PilY1 EF-hand loop identified in the crystal structure 
controls the opposing forces of pilus extension and retraction.  Thus, PilY1 is an essential, 
calcium-dependent regulator of bacterial twitching motility. 
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2.2 INTRODUCTION 
 
The pathogenesis of bacterial infections typically depends on microbial adherence to 
host tissue, aggregation of the pathogen at the site of infection, and subsequent 
dissemination to other anatomical sites within the host.  Type IV pili (T4P) are thin surface 
filaments involved in biofilm formation, bacterial aggregation and microbial adherence to 
biotic and abiotic surfaces. T4P biogenesis requires more than a dozen proteins conserved 
across a range of bacterial species [1]. A subset of bacteria, including the opportunistic 
human pathogen Pseudomonas aeruginosa, cyclically extend and retract their T4P, 
facilitating a form of surface movement termed twitching motility [2,3,4]. Retractile T4P are 
required for P. aeruginosa adherence to host tissue, virulence and dissemination of infection 
[5,6,7]. 
 
The pilin subunits that form T4P are incapable of self-assembly. Instead, pilus 
extension and retraction requires repeated rounds of pilin polymerization and 
depolymerization, both of which demand ATP hydrolysis [8,9]. In P. aeruginosa, the 
cytoplasmic ATPase PilB drives the assembly of pilin monomers into mature T4P [8,10], 
while the structurally related cytoplasmic ATPase PilT disassembles T4P back into pilin 
monomers [8,11,12]. Loss-of-function mutations in PilT result in the loss of twitching motility 
due to the inability of formed pilus fibers to retract [12]. The C-terminal half of the 117-kDa P. 
aeruginosa PilY1 protein shares sequence homology with the C-terminal domain (CTD) of 
the PilC proteins of pathogenic Neisseria species; in contrast, the N-terminal regions of the 
PilCs and PilY1 are divergent in sequence [13]. While the PilC proteins from Neisseria have 
been implicated in antagonizing pilus retraction by the pilus biogenesis ATPase PilT, the N-
terminal domains of these proteins appear critical for host cell attachment [14,15].  Thus, we 
hypothesized that the conserved CTDs of PilY1 and PilC may play a common role in T4P 
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biogenesis rather than adhesion, and pursued a structural and functional analysis of the 
CTD from Pseudomonas aeruginosa PilY1. 
 
2.3 RESULTS 
 
2.3.1 PilY1 Exhibits a Modified β-Propeller Fold 
Examination of the primary sequence of PilY1 from P. aeruginosa strain PAK 
revealed conservation between its C-terminal 550 residues and the same regions of the PilC 
proteins from Neisseria, and a predicted structural homology to the eight-bladed -propeller 
fold exhibited by a range of proteins [16,17].  Thus, we overexpressed, purified and 
crystallized the PilY1 CTD (amino acids 614-1163) for examination by x-ray diffraction.  
Native diffraction data were collected to 2.1 Å resolution (Table I); however, attempts to 
determine the structure using existing β-propeller search models or by isomorphous 
replacement methods were not successful.  PilY1 CTD contains only six methionine 
residues, which upon selenomethionine substitution failed to produce an adequate signal to 
support structure determination by anomalous dispersion [18].  To overcome this problem, a 
series of single leucine-to-methionine (L-M) substitutions were placed in the PilY1 CTD to 
provide additional sites for single wavelength anomalous dispersion (SAD) phasing 
(Supplemental Figures 2.1- 2.2).  After several attempts, three L-M substitutions (at 
positions 712, 812, 823) were successfully combined, crystallized, and generated clear 
selenomethionine fluorescence signal upon examination in the x-ray beam.  The structure 
was determined by SAD phasing using crystals containing nine total selenomethionine 
residues per protein monomer. 
 
The structured 505 residues of the PilY1 CTD exhibit a seven-bladed modified β-
propeller fold composed of 31 β-strands and 9 α-helices (Figure 2.1A; Supplemental Figures 
16 
 
2.1- 2.2; residues at the termini, as well as 713-721 and 1061-1068 were disordered and are 
not in the refined model).  Blades I through IV are 4-stranded antiparallel β-sheets and align 
well with blades of a canonical β-propeller enzyme, quinohemoprotein alcohol 
dehydrogenase from Comamonas testosteroni (RCSB 1KB0; overall RMSD of 3.6 Å over 
290 equivalent Cα positions with 15% sequence identity; Figure 2.1B) [16].  This β-propeller 
enzyme was identified by Phyre to align with the PilY1 predicted structure (E-value 0.014, 
95% certainty) [16]. Blades V through VII of the PilY1 CTD, however, deviate from the 
standard β-propeller fold and align poorly with established β-propellers.  Blade V contains a 
fifth strand (β20) that is shared with blade VI.  Blade VI is composed of six strands, including 
β20, and maintains an insert containing a short helix and β-turn-β motif (α9, β26-27).  
Finally, blade VII is truncated and composed of three relatively short strands.   
 
 WD40 β-propeller proteins mediate protein-protein interactions via surface contacts 
at the propeller center [19].  Superposition of the PilY1 CTD structure onto that of the seven-
bladed β-propeller WDR5, complexed with a lysine 4-containing histone H3 peptide, 
revealed an RMSD of 3.9 Å over 261 equivalent Cα positions sharing only 12% sequence 
identity [20].  Blades I-IV of the PilY1 CTD align well with the first four blades of WDR5, 
while the last three blades of each protein deviate more significantly in structure 
(Supplemental Figure 2.3).  However, helices 4 and 7 of PilY1 appear to block the surface 
site used by WDR5 to interact with peptide [19]. Both helices are predicted to be conserved 
in the C-terminal domains of the related Neisseria PilC proteins (Supplemental Figure 2.2) 
[17].  These observations suggest that PilY1 and related pilus biogenesis factors do not 
mediate protein-protein interactions using the canonical WD40 surface-binding site. 
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2.3.2 PilY1 Contains a Unique Calcium Binding Loop 
A strong |Fo|-|Fc| electron density peak in the PilY1 CTD structure was interpreted as 
a calcium atom based on the observed coordination by three aspartic acid side chains (851, 
855, 859), one asparagine side chain (853), one main-chain carbonyl oxygen of valine 857, 
and one water (Figure 2.2A; see also Supplemental Figure 2.1). The calcium binding 
observed in PilY1 is nearly identical to that seen in the canonical EF-hand Ca-binding motifs 
(Figure 2B; Supplemental Figure 2.4) [21]. PilY1 and EF hands both employ seven contacts 
to the bound calcium ion, including one from a water molecule and one bidentate contact via 
an acidic side chain.  PilY1 is unique, however, in that it achieves this calcium chelation 
using a stretch of only nine amino acids (851-859) in a loop between two β -strands (β 13 
and β 14) rather than the twelve residues between two α-helices typically observed in the 
EF-hands [21].  In addition, the carboxylic acid group of the bidentate Asp-859 residue is 
rotated nearly 90 with respect to the equivalent residue in EF-hand proteins [21]. Asp-859 
forms a hydrogen bond with His-797, which is conserved in PilY1 proteins of known 
sequence. The calcium-chelating residues observed in the structure are conserved in the 
PilY1s of known sequence and in the related PilCs, with the exception that Asn-853 is 
replaced with an aspartic acid in the Neisseria proteins (Figure 2.2C; Supplemental Figure 
2.2).  This modified EF-hand motif is also present in PilY1 orthologues found in other 
bacteria that utilize T4P, including the human pathogen Kingella kingae.  Thus, a novel 
calcium-binding site appears to be conserved in the C-terminal domains of pilus biogenesis 
proteins related to PilY1. 
 
Measurement of calcium binding affinity using a fluorescence competition assay 
established that purified PilY1 CTD exhibits a Kd of 2.6 µM for calcium (Figure 2.2D), which 
is similar to the affinities reported for traditional EF-hand proteins [22].  Titration with 
increasing concentrations of magnesium chloride reveals that this cation does not bind to 
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PilY1.  Mutation of the calcium chelating residue Asp-859 to alanine eliminates specific 
calcium binding by the protein (Figure 2.2D).  Removal of calcium either by Chelex-100 or 
by mutating a chelating residue did not change the overall structure (as measured by 
circular dichroism spectropolarimetry; Supplemental Figure 2.6) or melting temperature 
(Supplemental Figure 2.7) of the PilY1 CTD [23].  Additional mutations D851A, N853, and 
D855A were made to PilY1, all of which eliminated calcium binding and did not affect the 
overall secondary structure (Figure Ad 2.1A-C, 2.2A-C). Thus, calcium binding appears not 
to play a role in the overall structure of the PilY1 C-terminal domain.  
 
2.3.3 Calcium Binding and Release by PilY1 are Essential for Functional Pili 
Expression of mutant versions of PilY1 in P. aeruginosa revealed that calcium 
binding and release are essential for pilus production and twitching motility. To examine the 
phenotypic consequences of altering the PilY1 calcium-binding site on T4P production and 
function, we engineered plasmid-encoded versions of full-length wild-type PilY1 and PilY1 
carrying the D859A substitution.  Both proteins were expressed to native levels in a P. 
aeruginosa strain in which the chromosomal pilY1 gene was deleted (Supplemental Figure 
2.8). The PilY1minus strain is devoid of surface T4P, lacks measurable twitching motility, and 
is phenotypically indistinguishable from a non-piliated PilAminus strain, which does not 
produce the major T4P subunit, pilin (Figures 2.3A-B). Complementation of the PilY1minus 
strain with plasmid-expressed PilY1 restored twitching motility and pilus production to wild 
type levels (Figures 2.3A-B). In contrast, complementation of the PilY1minus strain with full-
length PilY1 D859A resulted in significantly less twitching motility (p<0.001) (Figure 2.3A). 
The level of surface T4P produced by the PilY1 D859A expressing strain was also 
dramatically reduced compared to wild type and likely accounts for the observed defect in 
twitching motility (Figure 2.3B).  
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PilY1 was previously shown to traffic to the surface T4P fraction [13] (Supplemental 
Figure 2.8), where it presumably functions through a direct association with the pilus fiber. 
To determine whether the defect in twitching observed with the D859A form of PilY1 was 
caused by disrupted pilus assembly/extension or increased pilus retraction, the PilY1 D859A 
mutant was expressed in a mutant strain lacking the PilT-retraction ATPase (PilTminus, 
PilY1minus strain). These bacteria regained the ability to produce normal levels of T4P, and 
the mutant PilY1 protein was capable of trafficking to the sheared pilus fraction (Figures 
2.3C-F).  This result indicates that the loss of surface pili observed with the PilY1 D859A 
mutant is caused by PilT-mediated pilus retraction. In the presence of PilT, the D859A form 
of PilY1 is incapable of antagonizing PilT-mediated pilus retraction despite normal trafficking 
of the protein.  We conclude that the calcium-binding site in the PilY1 CTD is necessary for 
normal pilus function by antagonizing the retractile activity of PilT. 
 
We then created a mutation in full-length PilY1 designed to mimic calcium binding 
and to potentially render the protein calcium-insensitive.  Specifically, a lysine residue was 
substituted for the bidentate calcium chelating Asp-859 residue (D859K).  While a lysine 
residue is not equivalent to a divalent metal ion, modeling of the D859K substitution 
mutation indicates that the α-amino group of lysine would be expected to form a salt bridge 
with the two proximal aspartic acids at 851 and 855 (Supplemental Figure 9).  Purified 
D859K PilY1 CTD does not bind calcium, and is not distinct in structure or melting 
temperature from the wild type CTD (Supplemental Figures 2.5- 2.7).  When expressed to 
native levels in the P. aeruginosa PilY1minus strain (Supplemental Figure 2.8), the full-length 
PilY1 D859K mutant was significantly reduced for bacterial twitching motility (p<0.001) 
compared to the same strain expressing wild type PilY1 (Figure 2.3A). Interestingly, the level 
of surface pilus production in the PilY1 D859K expressing strain was equivalent to that of 
the wild type strain (Figure 2.3B), indicating that reduced fiber production does not account 
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for the twitching motility defect. PilY1 D859K was capable of trafficking to the surface T4P 
fraction when expressed in both a pilY1 mutant background (Supplemental Figure 2.8) and 
a PilTminus, PilY1minus strain (Figures 2.3C-F).  Thus, using the crystal structure as a guide, 
we produced a single-site mutation that dramatically alters pilus function without affecting 
pilus production.  Based on these data, we conclude that the release of calcium by PilY1 is 
required for PilT-dependent fiber retraction and twitching motility. 
 
Finally, we tested whether the calcium chelator EGTA impacts P. aeruginosa pilus 
production.  We found that EGTA reduces the levels of surface pili present on bacteria 
expressing wild-type PilY1 while the non-retractile PilTminus strain is blind to calcium chelation 
(Figure 2.4A). Similarly, the D859K form of PilY1 is insensitive to the effects of EGTA and 
supports the production of wild-type levels of surface pili (Figure 2.4A). These data show 
that the PilY1 D859K mutant, mimicking the calcium bound state of PilY1, has increased 
capacity to antagonize PilT-mediated pilus retraction.  Taken together, these cell-based 
studies support the conclusion that both calcium binding and calcium release by the unique 
site in PilY1 are essential for the proper regulation of pilus retraction dynamics and twitching 
motility. 
 
2.4 DISCUSSION 
Based on the structural and functional data presented here, we propose that the 
PilY1 C-terminal domain exists in two critical states: calcium-bound, which inhibits PilT-
mediated pilus retraction, and calcium-free, which does not inhibit PilT and allows pilus 
retraction to proceed.  We further propose that the interconversion between these two states 
in wild-type PilY1 is required for the cycles of pilus extension and retraction necessary for 
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twitching motility (Figure 2.4B, top). The D859A mutant form of PilY1 appears to mimic the 
calcium-free state of the protein, and is not capable of antagonizing PilT-mediated 
retraction; thus, the equilibrium is shifted toward retraction, similar to that seen with the 
PilY1minus strain (Figure 2.4B).  Calcium chelation by EGTA also shifts the equilibrium toward 
retraction. In contrast, the D859K variant mimics the calcium-bound state, shifting the 
equilibrium toward pilus extension and producing an effect similar to that seen with the 
PilTminus strain (Figure 2.4B). The relatively moderate 2 µM calcium binding affinity exhibited 
by PilY1 is in the range where cycles of calcium binding and release would be expected to 
be physiologically relevant. Thus, we conclude that PilY1 acts as a calcium-dependent 
regulator of the opposing forces responsible for T4P-mediated twitching motility. However, 
we stress that this is a functional hypothesis; the physical contacts between PilY1 and other 
factors necessary to achieve this regulation have yet to be elucidated. It is interesting to 
note that calcium binding by bacterial pseudopilins has recently been shown to be critical for 
functional type II secretion, a process believed to be analogous to T4P biogenesis and 
function [24].  Thus, calcium may play an important role in several aspects of pilus 
biogenesis and regulation. 
Twitching motility mediated by PilY1’s influence on the PilB/PilT oscillatory motor 
would be expected to be coordinated with the significant >100 pN retractile motion exerted 
by the system once target cell adhesion occurs [25,26].  Surface translocation by twitching 
motility likely involves relatively moderate affinity contacts between a surface and T4P [26].  
For example, a disulfide loop in pilin, the major pilin subunit of the pilus fiber, has been 
proposed to be a point of contact between surfaces and T4P [27]. We propose that the 
cycles of pilus extension and retraction actuated by PilY1’s C-terminal domain may control 
twitching motility involving these moderate affinity contacts. Once target host cell contact 
has been achieved, however, the T4P system would be expected to convert to a rapidly 
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retracting, PilT-dominated state in which nearly nN forces are exerted [28,29].  The function 
of this mode would be to quickly draw the bacterial cell into close contact with host tissue 
cells. It is tempting to speculate that PilY1 may serve as the switch between twitching and 
rapid retraction. The sequence divergent N-terminal domains of PilY1 orthologues are 
proposed to perform target cell-specific adhesion; once that is achieved, perhaps the 
conserved C-terminal domains switch to the calcium-free state to facilitate rapid PilT-
mediated retraction [14,30,31]. 
 
The C-terminal domain of P. aeruginosa PilY1 shares significant sequence identity 
with the equivalent regions of the Neisseria PilC’s (Figure 2.2C), and similar levels of identity 
in PilY1 homologues from other human, plant, and marine infectious bacteria [17]. We find 
that each PilY1 homologue contains a predicted calcium-binding site highly similar in 
sequence to that observed in the PilY1 C-terminal domain (see Supplemental Figure 2.2).  
Thus, calcium binding and release may play an equally important role in pilus biogenesis 
and motility in organisms that maintain a PilY1 homologue.   Taken together, the structural 
and functional data we outline provide new insights into the complex functional regulation of 
the T4P essential to a range of human pathogenic bacteria. 
 
2.5 METHODS 
Structure Determination. PilY1 residues 615-1163 were cloned from genomic DNA from the 
PAK strain of P. aeruginosa (GenBank #EU234515), and overexpressed recombinantly in E. 
coli.  The protein was purified using Ni-affinity and size-exclusion chromatography steps to 
>95% purity, and crystallized in 0.3 M sodium malonate (pH 6.5), 20% (w/v) PEG 3350, 50 
mM DTT, 30 mM ammonium phosphate, and 4-8% trifluoroethanol.  Residues 614-1163 of 
PilY1 contained only five methionine residues; as such, crystals containing 
selenomethionine-substituted protein failed to produce sufficient signal to allow structure 
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determination. L712M, L813M and L823M mutations were successfully generated, 
combined, expressed, purified and crystallized in PilY1 specimen sufficient for x-ray data 
collected.  Diffraction data to 2.8  Å resolution were collected at the peak wavelength (0.979 
Å) for selenium single-wavelength anomalous dispersion (SAD) phasing (Table 1), and 
indexed and scaled in space group C2 using HKL3000 [32,33]. Automated model building 
correctly built 30% of the final structure; complete building and refinement was 
accomplished using COOT and CNS, respectively [34,35].  Once the selenomethionine-
substituted structure was refined at 2.8 Å resolution, it was used in molecular replacement to 
solve the 2.1 Å native structure, which was refined using COOT and CNS to the final 
statistics shown in Table 1 [34,35].   
Calcium Binding and Biophysical Studies: Calcium was removed from purified PilY1 using 
Chelex-100 (BioRad) prior to biophysical studies [23]. A binding curve for Oregon Green® 
488 BAPTA-5N was measured on a PHERAstar (BMGLabtech) at 488 nm and the Kd 
established at 10.1 µM. WT, D851A, N853A, D855A, D859A, and D859K PilY1 CTD was 
serial diluted 2 fold to calculate PilY1 CTD Kd for calcium binding, if applicable.  For 
biophysical characterizations via circular dichroism spectropolarimetry, a wavelength scan 
from 195-260 was performed at 22 oC. Thermal denaturation protein samples were 
measured 210 nm at a range of 10 oC to 85 oC. 
Isolation of Surface T4P: P. aeruginosa strains were spread on LB agar plates and grown 
until confluent. Bacteria were collected and suspended in 1 ml 0.15M NaCl/0.2% 
formaldehyde and vortexed vigorously for 1 minute to release surface T4P.  Bacterial cells 
were removed by centrifugation at 12,000 x g for 5 minutes. T4P fractions were separated 
by SDS-PAGE  (18% polyacrylamide) and pilin visualized by GelCode Blue stain (Pierce).  
Twitching Motility: Bacteria were stab inoculated to the bottom of 100 mm tissue culture-
treated plates containing 5 ml LB agar (1% w/v). Plates were incubated for 40 hours at 37C 
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in a humidified incubator. Twitching motility was quantified by measuring the diameter of the 
subsurface zone of bacterial spread. 
Western Blots: Whole cell lysates and T4P fractions were separated on 18% (pilin) or 7.5% 
(PilY1) SDS-polyacrylamide gels and transferred to nitrocellulose or PVDF membranes, 
respectively.  Membranes were probed with PKL1 anti-pilin monoclonal antibody or anti-
PilY1 CTD rabbit serum. Horseradish peroxidase-conjugated secondary antibodies were 
used for the detection of specific antibody-antigen complexes. Blots were developed with 
chemiluminescence reagents and visualized via autoradiography. 
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2.7 FIGURE LEGENDS 
 
Figure 2.1  Crystal structure of the P. aeruginosa PilY1 CTD.  A. 2.1 Å resolution crystal 
structure of the P. aeruginosa PilY1 C-terminal domain, which begins at residue 644 and 
ends at 1148 and encompasses seven β-blades (I-VII; colored red, orange, yellow, green, 
blue, magenta and violet).  B.  Superposition of the seven-bladed PilY1 CTD β-propeller (red 
through violet) on the eight-bladed β-propeller of the quinohemoprotein alcohol 
dehydrogenase from Comamonas testosteroni (1KB0; grey). 
 
Figure 2.2 PilY1 calcium-binding site.  A.  The PilY1 calcium binding site is composed of 
aspartic acids 851, 855 and 859, as well as asparagine 853, the main chain carbonyl 
oxygen of valine 857, and a water molecule (red sphere).  Distances are in Å.  B. 
Superposition of the nine-residue calcium-binding site of PilY1 (green) on the canonical 
twelve-residue site in human calmodulin (CaM; cyan). The calcium atoms (Ca) and water 
molecules (W) are depicted as spheres. Viewed in roughly the same orientation as 2A.  C. 
Sequence conservation in the calcium binding sites of the PilY1 homologues PilC1 and 
PilC2 from Neisseria meningitidis (N.men.) and N. gonorrhoeae (N.gon.).   D.  The PilY1 
CTD binds to calcium with a Kd of 2.6 µM (black), while the Asp-859-Ala mutant form of the 
CTD exhibits only non-specific calcium binding (grey). Error represents standard error of the 
mean.   
 
Figure 2.3 The PilY1 calcium-binding site is essential for T4P production and function.  
A.  Twitching motility of P. aeruginosa (wt), or a pilY1 mutant expressing either empty vector 
(-), PilY1, or mutant versions of PilY1 (D859A or D859K).  The twitching motility zones 
produced by bacteria expressing mutant PilY1 were significantly (*, p< 0.001) reduced 
compared to those of bacteria expressing wild type PilY1.  B.  Coomassie Blue-stained gel 
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of pilin isolated from the bacterial surface. C-F.  Abolishing T4P retraction allows conditional 
localization of PilY1 to the bacterial surface.  C. Coomassie-stained gel of pilin isolated from 
the bacterial surface. D. Western blot of T4P-containing surface fractions probed with PilY1- 
specific antiserum. E. Western blot of whole cell lysates probed with a pilin-specific antibody. 
F. Western blot of whole cell lysates probed with a PilY1-specific antiserum. 
 
Figure 2.4  Calcium chelation impacts T4P production.  A.  Pilus preparations from a pilT 
mutant or a pilY1 mutant expressing either PilY1, or mutant versions of PilY1 grown in the 
presence (+) or absence (-) of the calcium chelator EGTA.  B.  Summary of the impact 
specific mutants have on pilus state.  Wild-type PilY1 appears to balance extension and 
retraction to produce twitching motility (boxed), while gene deletions, PilY1 site mutants, and 
the calcium chelator EGTA all significantly disrupt the equilibrium between pilus extension 
and retraction. 
 
 
2.8 SUPPLEMENTAL FIGURE LEGENDS 
 
Supplemental Figure 2.1 Topology diagram of the P. aeruginosa PilY1 CTD fold 
showing the positions of secondary structural elements (strands as arrows, helices as 
cylinders), disordered regions (dotted lines), the calcium binding site (green sphere), and 
the locations of the seven leucine-to-methionine mutations examined during structure 
determination. Colored as shown in Figure 1A. 
 
Supplemental Figure 2.2 Sequence alignment of the PilY1 CTDs from three 
Pseudomonas strains (PAK, the subject of this study; PA01, PA14) along with the 
PilC1’s from two Neisseria strains, N. meningitidis (NEIME) and N. gonorrhoeae 
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(NEIGO). Secondary structure elements, disordered regions, the calcium binding site, 
and the leucine-to-methionine mutations are indicated as in Supplemental Figure 1. 
 
Supplemental Figure 2.3 A.  Seven-bladed β-propeller structure of WDR5 (purple) 
complexed with an H3 peptide containing lysine-4 (yellow).  B. Seven-bladed β -propeller 
structure of the PilY1 CTD (cyan).  C.  Superposition of the β -propeller structures showing 
that the site employed by WDR5 for peptide binding is blocked by β helices 4 and 7 in PilY1. 
 
Supplemental Figure 2.4 Comparison of the ligand-to-calcium atom distances in PilY1 
and human calmodulin (CaM), as well as the sequences of the calcium binding sites in 
the two proteins. 
 
Supplemental Figure 2.5 Calcium binding curve for purified P. aeruginosa PilY1 D859K C-
terminal domain. 
 
Supplemental Figure 2.6 Circular dichroism spectropolarimetry wavelength scans for 
purified P. aeruginosa PilY1 C-terminal domain proteins in the presence and absence of 
calcium. 
 
Supplemental Figure 2.7 Melting temperature for purified P. aeruginosa PilY1 C-terminal 
domain proteins in different conditions as monitored by circular dichroism 
spectropolarimetry. 
 
Supplemental figure 2.8 A-D.  Modulation of calcium binding influences T4P production 
without altering pilin availability. A. Coomassie-stained gel of pilin isolated from the 
bacterial surface. B. Western blot of T4P-containing surface fractions probed with PilY1- 
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specific antiserum. C. Western blot of whole cell lysates probed with a pilin-specific 
antibody. D. Western blot of whole cell lysates probed with PilY1-specific antiserum. 
 
Supplemental Figure 2.9 Model of the Asp-859-Lys (D859K) mutation in the PilY1 C-
terminal domain calcium binding site. 
 
 
 
2.9 ADDITIONAL FIGURE LEGENDS 
 
 
Additional Figure 2.1 A-C Calcium binding curve for purified P. aeruginosa PilY1 A.  
D851A  B. N853A, and  C. D855A C-terminal domain. 
 
 
Additional Figure 2.2 A-C Circular dichroism spectropolarimetry wavelength scans for 
purified P. aeruginosa PilY1 A.  D851A,  B. N853A, and  C. D855A C-terminal domain 
proteins in the presence and absence of calcium. 
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Pseudomonas aeruginosa PilY1 Binds Integrin in an RGD- and Calcium-
Dependent Manner 
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3.1 SUMMARY 
 PilY1 is a type IV pilus (tfp)-associated protein from the opportunistic pathogen 
Pseudomonas aeruginosa that shares functional similarity with related proteins in infectious 
Neisseria and Kingella species. Previous data have shown that PilY1 acts as a calcium-
dependent pilus biogenesis factor necessary for twitching motility with a specific calcium 
binding site located at amino acids 850-859 in the 1,163 residue protein. In addition to 
motility, PilY1 is also thought to play an important role in the adhesion of P. aeruginosa tfp to 
host epithelial cells. Here, we show that PilY1 contains an integrin binding arginine-glycine-
aspartic acid (RGD) motif located at residues 619-621 in the PilY1 from the PAK strain of P. 
aeruginosa; this motif is conserved in the PilY1s from the other P. aeruginosa strains of 
known sequence. We demonstrate that purified PilY1 binds integrin in vitro in an RGD-
dependent manner. Furthermore, we identify a second calcium binding site (amino acids 
600-608) located ten residues upstream of the RGD. Eliminating calcium binding from this 
site using a D608A mutation abolished integrin binding; in contrast, a calcium binding mimic 
(D608K) preserved integrin binding. Finally, we show that the previously established PilY1 
calcium binding site at 851-859 also impacts the protein’s association with integrin. Taken 
together, these data indicate that PilY1 binds to integrin in an RGD- and calcium-dependent 
manner in vitro. As such, P. aeruginosa may employ these interactions to mediate host 
epithelial cell binding in vivo. 
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3.2 INTRODUCTION 
Pseudomonas aeruginosa is a Gram-negative, opportunistic pathogen prevalent in 
immunocompromised patients, burn victims, and people with cystic fibrosis. P. aeruginosa 
can infect any part of the body, but typically targets the respiratory tissues, skin abrasions, 
and the urinary tract [1]. This pathogen accounted for ~11% of the hospital-acquired 
infections reported in the U.S in 2002 [2,3], and has also been shown to infect other 
mammalian species, as well as insects and plants [4,5]. P. aeruginosa uses a range of 
methods to resist the effects of antibiotics, including efflux pumps, adaptive mutagenesis, 
and protective biofilms [6,7,8]. As such, Pseudomonas aeruginosa presents a significant 
challenge to human health. 
P. aeruginosa employs type IV pili (tfp) for twitching motility and infection.  The 
precise mechanism of host cell attachment has remained unclear, although evidence exists 
that loops of the major pilus structural subunit PilA exposed at the tip of the pilus fiber bind 
to gangliosides GM1 and GM2 [9]. In contrast, some data indicate that several P. 
aeruginosa clinical isolates, as well as laboratory strains, do not employ GM1 and GM2 
during host cell attachment [10,11].  As such, it has been proposed that other factors on the 
Pseudomonas tfp are involved in binding to target cells [12,13]. 
Recent studies have suggested that host cell integrin proteins play a role in 
Pseudomonas infection.   Anti-integrin antibodies were shown to reduce P. aeruginosa 
attachment to host cells [14]. Specifically, antibodies to the αVβ5 integrin and αVβ3 integrin 
were effective at disrupting P. aeruginosa binding to host cells, with antibodies to αVβ5 
integrin having the most pronounced effect [14]. Integrins are present on the epithelial cell 
surface of tissues infected by P. aeruginosa; indeed, αVβ5 integrin is highly expressed in the 
lungs [15]. The presence of P. aeruginosa has also been shown to increase the expression 
of integrin subunits αV, α5, and β1 in epithelial cells [16,17].  Integrins and integrin-like 
proteins are found widely in animals, plants, and insects, all targets of P. aeruginosa 
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infection [18]. Integrins are responsible for a range of cellular processes, including cell-cell 
attachment, cellular signaling, and angiogenesis [19]. The most common ligands for 
integrins are proteins that contain an arginine-glycine-aspartic acid (RGD) sequence, 
although other short peptides have also been found to mediate integrin-protein interactions 
(e.g., leucine-aspartic acid-valine or LDV).  
The PilC class of proteins in Neisseria gonorrhoeae, Neisseria meningitidis, and 
Kingella kingae have been characterized as tfp biogenesis factors and as proteins involved 
in adhering to target tissues [20,21,22]. Generally, PilC N-terminal regions are associated 
with adhesion domains, while the C-terminal domains regulate tfp biogenesis. P. aeruginosa 
PilY1 shares sequence homology with the C-terminal regions of the PilCs proteins, and this 
domain in PilY1 has been shown to be a calcium-mediated tfp biogenesis factor 
(Supplemental Table 3.1) [23]. Indeed, PilY1 is required for both twitching and swarming 
motility and adhesion to host cells [23,24,25]. The N-terminal domains of PilY1 and the PilCs 
share low sequence similarity, which might be expected if these domains are involved in 
target cell-specific activities.  The target tissues of the Neisseria strains and Kingella are 
likely to be distinct from those targeted by P. aeruginosa. Here, we focus on putative regions 
of PilY1 involved in host cell attachment and we show that purified PilY1 binds to integrins in 
an RGD- and calcium-dependent manner in vitro. 
 
3.3 RESULTS 
3.3.1 PilY1 Contains a Conserved Integrin Binding Motif 
Given the importance of the tfp associated PilY1 protein in host tissue adherence 
and the ability of antibodies targeting the RGD binding domains of αVβ5 and αVβ3 integrins 
to reduce interactions between P. aeruginosa and host cells, we examined PilY1’s sequence 
to locate possible integrin binding motifs (RGD or LDV) [14,25]. PilY1 was found to contain a 
conserved RGD motif (Figure 3.1A, B).  No other type IV pilus proteins or known surface 
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proteins in P. aeruginosa contained an RGD or other putative integrin binding sequence 
[26,27]. One RGD motif was found in each of the PilY1s of P. aeruginosa strains of known 
sequence. For example, in the PilY1 from P. aeruginosa strain K (PAK), the RGD is located 
at residues 619-621; however, in the PAO1 P. aeruginosa strain PilY1, the RGD is at 657-
659 (Figure 3.1B).  Based on these observations, we hypothesized that PilY1 binds to 
integrin in an RGD-dependent manner.  
 
3.3.2 PilY1 Binds Integrin in an RGD-Dependent Manner 
To test the hypothesis that PilY1’s RGD motif mediates contacts with integrins, we 
created a purified form of PilY1 that starts at amino acid 532 and extends to C-terminus of 
the protein (residue 1163) and tested the ability of 532-1163 PilY1 to bind to αVβ5 using an 
integrin binding assay. Titration of increasing concentrations of 532-1163 PilY1 showed that 
mid-nanomolar concentrations of this purified protein binds specifically to αVβ5 (Figure 
3.2A). Next, we employed synthetic RGDS and GRADSP peptides to compete with PilY1 
binding to αVβ5 integrin. We found that that the RGDS peptide significantly reduced PilY1 
binding to αVβ5 integrin (p<0.10), while the GRADSP control peptide had no effect (Figure 
3.2B). Because previous reports also indicated that PAK binding to host cells can be 
reduced by using an anti-αVβ3 integrin antibody, we also examined PilY1 binding to αVβ3. 
We found that purified 532-1163 PilY1 binds to αVβ3 integrin in an RGD-dependent manner, 
although with a lower apparent affinity than observed with αVβ5 integrin (Figure 3.2C) [14]. 
We therefore used αVβ5 as the primary integrin of this study. Finally, we tested two RGD 
mutants of 532-1163 PilY1, D621A (RGA) and ∆619-621 (∆RGD), for their ability to bind to 
αVβ5 integrin in vitro. Deleting the RGD residues or mutating the aspartic acid residue at 
position 621 to alanine significantly reduced the association of PilY1 with αVβ5 integrin 
(Figure 3.2D).  Importantly, these mutations did not alter the global secondary structure or 
the melting temperature of purified 532-1163 PilY1 (Figure 3.2E, Supplemental Table 3.2). 
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Taken together, these data indicate that P. aeruginosa PilY1 binds to integrins in vitro in an 
RGD-dependent manner.  
 
3.3.3 PilY1 has a Second Calcium Binding Site 
A second potential calcium binding site was noted in the sequence of P. aeruginosa 
PilY1 between residues 600 and 608, which is in close proximity to the RGD motif (619-621) 
described above (Figure 3.1A).  Recall that a calcium binding site at residues 851-859 in 
PilY1 was shown in previous work to be critical to tfp biogenesis and twitching motility [23].  
The sequences of the two calcium binding sites are closely related (Figure 3.3A), and the 
putative 600-608 site is conserved in PilY1s of known sequence (Figure 3.1B).  Indeed, in 
the P. aeruginosa PilY1 sequences examined, this second potential calcium binding site 
was always found 8-10 residues upstream of the conserved RGD motif (Figure 3.1B). To 
test the 600-608 site’s ability to bind calcium in purified 532-1163 PilY1, we eliminated the 
previously published calcium binding site using either a D859A or D859K mutation [23], and 
measured calcium binding. The D859A and D859K forms of 532-1163 PilY1 exhibited Kd‘s 
for calcium binding of 412 and 266 nM, respectively (Figure 3.3B). Thus, the 600-608 site 
appeared to bind calcium.  We next created corresponding mutations (D608A, D608K) in the 
532-1163 PilY1 construct, and found that these variants bound calcium with 2.3-2.4 µM 
affinity, similar to that reported previously for the 851-859 PilY1 site (Figure 3.3C) [23].  
Finally, we created a D608A/D859A double-mutant form of 532-1163 PilY1 and compared 
its calcium binding to wild-type 532-1163 PilY1.  We found that the double-mutant exhibited 
only non-specific calcium binding, while wild-type 532-1163 PilY1 associated with calcium 
with a 700 nM affinity (Figure 3.3D). The variant forms of 532-1163 PilY1 examined in vitro 
in these studies maintained an overall wild-type fold and melting temperature, indicating that 
these changes did not alter the stability of the proteins (Supplemental Figure 3.1A-E; 
Supplemental Table 3.2).  To further confirm that our 532-1163 construct of PilY1 contained 
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two calcium binding sites, we used isothermal titration calorimetry. Indeed, with wild type 
PilY1, we observed a binding site N value of 1.61 indicating that there were two calcium 
binding sites (Additional Figure 3.1A). However, when we used the D608A mutation, we 
observed an N value of .946 indicating that one calcium binding site remained (Additional 
Figure 3.1B). 
Finally, mutations in the RGD sequence adjacent to the 600-608 site did not alter 
calcium binding by these purified forms of 532-1163 PilY1 (Supplemental Figure 3.2A).  
Taken together, these observations support the conclusion that purified 532-1163 PilY1 
contains two calcium binding sites, the previously characterized one at 851-859 and a newly 
identified one at 600-608 that is ten residues N-terminal to PilY1’s RGD motif.   
 
3.3.4 PilY1 Binds Integrin in a Calcium Dependent Manner 
Because the 600-608 calcium binding site in PilY1 is close in sequence to the RGD 
motif, we next sought to examine whether calcium binding impacted the association 
between 532-1163 PilY1 and integrin. We found that D859A, D859K, and D608K mutant 
forms of 532-1163 PilY1 exhibit wild-type or only slightly reduced binding to αVβ5; in 
contrast, the D608A mutant of purified PilY1 was significantly inhibited in its binding to this 
integrin (Figure 3.4A).  Thus, eliminating the charged D608 side chain proximal to the RGD 
motif impacted PilY1’s interaction with αVβ5.  We then examined double mutant forms of 
532-1163 PilY1 and found that the two calcium binding sites interacted functionally with 
respect to integrin binding (Figure 3.4B).  For example, the D608A/D859A variant of 532-
1163 PilY1 shows nearly wild-type levels of αVβ5 binding (Figure 3.4B); recall that the 
D608A form of PilY1 exhibited little integrin binding in vitro (Figure 3.4A).  Thus, D859A 
appears to act as a dominant positive over the D608A mutation.  Similarly, the 
D608K/D859A PilY1 shows increased integrin binding relatively to wild-type (Figure 3.4B).  
In contrast, adding the D859K mutation to either D608A or D608K in PilY1 had no impact on 
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integrin binding relative to the 608 mutants alone (Figure 3.4B).  Taken together, these data 
suggest that both calcium binding sites in PilY1 impact integrin binding in vitro.  Note that 
the single- and double-mutants considered here did not bind calcium (Supplemental Figure 
3.2B), and exhibited wild-type CD spectra and melting temperatures (Supplemental Figure 
3.1A-E, Supplemental Table 3.2), indicating that the overall structure of these purified 
proteins was not altered. 
The crystal structure of the C-terminal domain of PilY1 does not contain the 600-621 
region; as such, it is not known whether the two calcium binding sites are in close structural 
proximity.  However, it is possible that they interact physically, and that the functional impact 
of one upon the other is via the swapping of an aspartic acid from one site (e.g., D851 or 
D855) into the other site (600-608).  To test this hypothesis, we created two triple mutant 
forms of 532-1163 PilY1, D608A/D851A/D859A and D608A/D855A/D859A, and one 
quadruple mutant form, D608A/D851A/D855A/D859A. Both triple mutants and the 
quadruple mutant show wild type levels of binding (Supplemental Figure 3.3). Thus, we 
conclude that an interaction between the two calcium binding sites in PilY1 is not primarily 
associated with aspartic acids in one site helping to coordinate calcium in the other site. 
Additionally, to test whether the D608A/D859A mutation created an unknown secondary 
integrin binding site, consequently, leading to wild type binding, we mutated the RGD motif 
aspartic acid to alanine and tested integrin binding. Similarly to the D621A (RGA) single 
mutation, a mutation to the RGD motif in the D608A/D859A severely reduced binding 
(Additional Figure 3.2). However, taken together, these data indicated that a functional 
interaction between the two calcium binding sites in PilY1 impacts the ability of the RGD 
motif in this protein to bind to integrins in vitro. 
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3.4 DISCUSSION  
P. aeruginosa is an established and increasingly antibiotic resistant pathogen that 
predominantly infects patients with compromised defense mechanisms.  Toward this end, 
we sought to understand how P. aeruginosa binds to host cells, a necessary first step in 
infection.  We focused on the type IV pilus-associated protein PilY1, which is involved in 
bacterial motility and is related in sequence to factors in other bacteria required for host cell 
binding.  We show that PilY1 contains an integrin binding RGD motif that mediates contact 
between purified PilY1 and integrin proteins in vitro.  Additionally, we show that PilY1 
contains two calcium binding sites and that each site impacts the protein’s ability to 
associate with integrin (Figure 3.4C).  Both the calcium binding sites and the RGD motif are 
conserved in all PilY1 sequences from P. aeruginosa strains reported to date (Figure 3.1B). 
It was not anticipated that the PilY1 calcium binding sites, particularly the one distal 
(851-859) to the RGD sequence, would impact integrin binding.  In fact, D859A can be seen 
as a dominant positive with respect to integrin binding (Figure 3.4C).  For example, while the 
D608A mutant form of PilY1 is significantly reduced in integrin binding, combining it with 
D859A to create a D608A/D859A double-mutant produces a protein that is capable of 
binding to integrin (Figure 3.4B). Further, a D608K/D859A double-mutant exhibits higher 
integrin binding than either single mutant or the wild-type protein (Figure 3.4B).  In spite of 
these in vitro data, however, the molecular contacts involved in these effects are not clear, 
in part because the region between residues 600 and 643 in PilY1 has not been elucidated 
structurally.  It is tempting to speculate that a physical association exists between the two 
calcium binding sites that impacts RGD presentation for integrin binding.  Such speculation 
is supported by the data outlined here, but remains speculation until future studies to 
examine the structure of this region of PilY1 are complete.  
One hypothesis on how calcium binding plays a role in RGD-mediated binding is 
based on a putative calcium binding site in the αVβ3 structure (Additional Figure 3.3A). 
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αVβ3 integrin has eight known calcium/manganese binding sites identified by the crystal 
structures and one putative consensus aspartic acid - x - aspartic acid - x - aspartic acid - 
glycine (DxDxDG) calcium binding site in a loop region of the αV subunit [28,29]. This 
putative DxDxDG site is located 3.0 Å away from the phenylalanine-tyrosine-tryptophan 
(FYW) residues in αV subunit that are used to mediate RGD substrate binding (Additional 
Figure 3.3B) [29,30]. The αVβ3 structure shows the binding to an RGD peptide, not to a 
protein substrate, and thus is small enough to fit in the groove between the FYW and the 
putative consensus calcium binding domain. Although this putative consensus calcium 
binding site in integrin does not have metal bound in either structure, the site could still be 
playing a role in the local area dynamics if the protein substrate either contributes charge or 
eases the steric burden that this unbound calcium binding site could be imposing to prevent 
binding.  
When the 532-1163 construct of PilY1 is modeled using I-TASSER, and the top 
generated .pdb is aligned with the RGD of the integrin structure, the unbound 600-608 PilY1 
calcium binding site is 6.0 Å from the putative consensus DxDxDG calcium binding domain 
in the αV subunit (Additional Figure 3.3C) [29,30,31,32]. It is unlikely that the 600-608 site in 
PilY1 is donating calcium to the new putative integrin calcium binding site as when PilY1 has 
no calcium to donate (i.e. the D608K or D608K/D859A mutations), integrin binding still 
occurs. However, there are four aspartic acids in the 600-608 calcium binding site that could 
lead to dynamic repelling motion from each other without the metal present. Thus, it is 
enticing to speculate that the bound 600-608 PilY1 calcium binding site could be easing a 
steric hindrance otherwise caused by the unbound 600-608 calcium binding site of PilY1 in 
respect to PilY1 binding to integrin or at the very least providing room for the putative 
integrin calcium binding site to move away from the FYW to facilitate binding. 
Also of note, the aspartic acid in the RGD peptide in the αVβ3 structure is 2.7 Å 
away from the manganese in the structure (Additional Figure 3.3C) [29]. This measurement 
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is consistent with previous distance measurements of calcium bond lengths to the chelating 
residue. [23]. As measured in this study, there is a high binding affinity for PilY1 to αVβ5 
(Figure 3.2A). This high affinity could be contributed by the proximity of the aspartic acid in 
the substrate RGD as it helps to coordinate the metal. This observation could also explain 
why the aspartic acid being mutated to alanine causes a significant reduction in overall 
substrate:integrin binding but in the literature, a mutation to glutamic acid yields binding at 
wild type levels (Figure 3.2B) [33]. 
Integrins and integrin-like proteins are present in plants, insects, and the animal 
kingdom.  They are up-regulated during cellular stress and recovery [34,35,36]; indeed, the 
presence of P. aeruginosa itself up-regulates the expression levels of the αV integrin subunit 
[16]. In addition, integrins are established targets for bacterial pathogens. Bordetella 
pertussis protein pertactin, containing two RGD motifs, has been shown to adhere to 
Chinese hamster ovary cells in an RGD-dependent manner [37,38]. Pertactin is a member 
of the auto-transporter family, many of which contain RGD motifs mediating adherence to 
integrins [39]. However, there are conflicting data on whether auto-transporter RGDs are 
relevant in mouse models of infection [40]. Still, other in vitro and in vivo studies have shown 
that the following bacteria bind integrin in an RGD-dependent manner: Pyrenophora tritici-
repentis (a wheat pathogen), Mycoplasma conjunctivae (sheep pathogen), and the 
mammalian pathogens Klebsiella pneumoniae and Helicobacter pylori [41,42,43,44]. 
Integrins are also known targets for viral pathogens. Proteins in hepatitis C virus, 
coxsackievirus A9, human herpes virus 8, Epstein-Barr virus, and adenovirus bind to host 
cells in an RGD dependent manner [45,46,47,48,49].  In summary, integrins have the 
potential to be important target proteins for PilY1-mediated attachment of P. aeruginosa. 
Interestingly, calcium has also been shown to play a vital role in host RGD 
substrate:integrin binding events (Table 3.1). Calcium binding helps in the folding of the 
blood clotting factor fibrinogen, and it protects against cleavage and degradation of the 
59 
hemostasis protein von Wildenbrand factor and the elastin scaffold protein fibrillin (Table 
3.1) [50,51,52,53]. Some integrin substrates, such as  thrombospondin, use cooperative 
calcium binding at multiple sites to facilitate integrin binding, while calcium increases 
adhesion in tenascin, vitronectin, and osteopontin to target integrins (Table 3.1) 
[54,55,56,57,58] . Thus, there is precedent for calcium regulation of RGD-mediated contacts 
with integrins. 
PilY1 is an established pilus biogenesis factor [23] and has been implicated in P. 
aeruginosa adhesion to host cells by functional studies [25] and due to its homology to the 
PilCs adhesin proteins of Neisseria [59]. Here, we provide evidence that PilY1 serves as an 
adhesin that binds to integrins in an RGD-dependent manner. Furthermore, we show that 
integrin binding is regulated by two distinct calcium binding sites in PilY1.  These data 
provide an in vitro advance in our understanding of PilY1 structure and function.  It will be of 
interest to determine in future studies whether PilY1 and integrins are involved in P. 
aeruginosa attachment to host cells in vivo. 
 
3.5 METHODS 
PilY1 constructs and protein purification 
Site-directed mutagenesis was performed to produce D608A, D608K, D621A, ∆619-
621, D859A, D859K, D608A/D859A, D608A/D859K, D608K/D859A, D608K/D859K, 
D608A/D621A/D859A, D608A/D851A/D859A, D608A/D855A/D859A, and 
D608A/D851A/D855A/D859A mutants in a pDONR vector containing PilY1. Amino acids 
532-1163 were cloned out of the pDONR vector for entry into pMCSG7 for protein 
expression. Vectors were transformed into BL21 Gold (Stratagene) on ampicillin plates 
overnight and a single colony was used to inoculate a 100mL LB flask overnight containing 
50µM/mL ampicillin. Cell cultures were centrifuged at 3000 x g and the supernatant was 
discarded. The resultant pellet was used to inoculate a 1.5 L shaker flask of Terrific Broth 
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with 50µL of antifoam (Sigma-Aldrich) and 50µg/mL ampicillin. Cells were grown at 37 oC 
until OD600 reached 0.6-0.8. Temperature was reduced to 18 oC and protein expression was 
induced with 0.5 mM IPTG. Cells were grown overnight and harvested by centrifugation 
6000 x g at for 15 minutes at 4 oC, and pellets were stored at -80 oC. 
Cells pellets were thawed using buffer consisting of 25 mM HEPES pH 7.5, 150 mM 
NaCl, 10 mM imidazole, 5% glycerol, DNase and protease inhibitor tablets (Roche). Cells 
were sonicated and cell lysate was separated into soluble and insoluble fractions using high-
speed centrifugation. The soluble fraction was filtered then nickel purified, buffer exchanged, 
and separated using an S200 gel filtration column on an ÄKTAxpress™ (GE HealthCare). If 
necessary, protein and storage buffers were chelated by Chelex-100 to remove bound 
calcium (Bio-Rad Laboratories). Purified proteins were concentrated to ~100 µM, frozen, 
and stored at -80 oC. 
 
Integrin binding assay 
Costar EIA/RIA stripwell high binding plates were coated with either 2 μg of purified 
αVβ5 integrin or 2 μg of purified αVβ3 integrin (Millipore) for the experimental wells, or the 
molar equivalent of BSA for the control wells, at 100 μL in 100 mM sodium bicarbonate 
buffer pH 9.6 (Abcam) for 16 hours at 4oC. Plates were washed 1 x with 300 μL of PBS. 
Wells were then blocked with 1% BSA in PBS for one hour at room temperature. Plates 
were washed 1 x with PBS and 100μg/mL of PilY1 (Wild Type, D621A, ∆619-621, D608A, 
D608K, D859A, D859K, D608A/D859A, D608A/D859K, D608K/D859A, D608K/D859K, 
D608A/D621A/D859A, D608A/D851A/D859A, D608A/D855A/D859A, or 
D608A/D851A/D855A/D859A) in binding buffer (50 mM Tris pH 7.8, 100 mM NaCl 2mM 
CaCl2, 1 mM MgCl2, 1 mM MnCl2, and 0.1% Triton) was added to each well including the 
BSA control wells for 6 hours at 16 oC with or without RGDS peptide (inhibitor), GRADSP 
peptide (control), or no peptide. Plates were then washed 3 x with PBST (0.1% Tween-20) 
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and 3 x with PBS before adding rabbit αPilY1 polyclonal antibody 1:500 per well in 1% BSA 
in PBS overnight for 16 hours at 4oC. Plates were then washed 3 times with PBST and 3 x 
with PBS before adding the Alexa fluor 488 f(ab’)2 fragment goat anti-rabbit (Invitrogen) 
1:5000 in 1% BSA in PBS protected from light at room temperature for 1 hour. Plates were 
then washed 3 x with PBST, 3 x with PBS, then dried. Plates were read on a PHERAstar 
(BMG LabTech). The experimental and control well averages and standard error of the 
mean (SEM) were calculated, and then the control average was subtracted from the 
experimental values and the errors were compounded using the 
equation√ሺሺ݁ݔ݌݁ݎ݅݉݁݊ݐ݈ܽ	ܵܧܯሻଶ ൅	ሺܿ݋݊ݐݎ݋݈	ܵܧܯሻଶሻሻ. 
 
Calcium binding assay 
A binding curve for Oregon Green® 488 BAPTA-5N, hexapotassium salt (Invitrogen) 
in 25 mM HEPES pH 7.5, 150mM NaCl, and 5% glycerol was measured on a PHERAstar 
(BMGLabtech) at 488 nm. With 20 µM Oregon Green and 2 µM CaCl2, PilY1 constructs 
were serial diluted 1.5-3 fold from ~100 µM to ~1 nM to obtain an EC50 which was then 
used to calculate the respective PilY1 Kd for calcium as described previously[23]. 
 
Isothermal titration calorimetry 
 Chelated 532-1163 wild type or D608A PilY1 protein was brought to 20 µM and 
CaCl2 was brought to 300 µM in chelated 25 mM HEPES pH 7.5, 150mM NaCl, and 5% 
glycerol. Machine temperature was set to 23oC and after the first injection, there were 19 
equal injections. ITC measurements were carried out on an Auto-iTC200 (MicroCal/GE 
Healthcare). 
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Circular dichroism and thermal denaturation 
Protein samples were buffer exchanged into chelated 10 mM KxHxPO4 50 mM NaF 
pH 7.7 buffer and brought to 5µM with or without the addition of CaCl2. A wavelength scan 
from 200-260 λ was performed on a Circular Dichroism Spectrometer 62 DS (Aviv) at 16 oC 
with a 10 second averaging time. Melting temperatures were measures at λ 214 from 3 oC to 
95 oC at one degree increments with a 10 second averaging time. 
 
Structure images 
 All images of PilY1 and αVβ5 were created using The PyMOL Molecular Graphics 
System, Version 1.2r3pre, Schrödinger, LLC. 
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3.7 FIGURE LEGENDS 
 
Figure 3.1 P. aeruginosa PilY1 strains contain conserved integrin binding residues RGD 
and conserved putative calcium binding site. (a) A bar representation of PilY1. The 
consensus c-terminal pilus biogenesis domain is in blue and the green represents the n-
terminal addition to the previously examined construct. Calcium binding motifs are 
highlighted in yellow and the RGD is highlighted in orange. (b) Five varying strains of P. 
aeruginosa PilY1 were aligned using the biology workbench server [26,27]. Blue residues 
and an “*” corresponds to identical residues throughout the 5 strains, green residues and a 
“:” correspond to highly conserved residues, and navy residues and a “.” corresponds to 
mildly conserved residues (e.g. alanine and leucine).  Reference numbers are for PAK_287 
PilY1 (the strain used in this study). 
 
Figure 3.2 Purified PilY1 binds to integrin in an RGD dependent manner. (a) PilY1 was 
titrated onto a solid phase binding assay keeping the concentration of αVβ5 integrin 
constant at 2μg/mL. The curve was fit to the ligand binding, one site saturation equation f = 
Bmax*abs(x)/(Kd + abs(x)) with an r2 = 0 .98. The Kd was calculated at 164nM ±38. (b-d) 
Wild type PilY1 was established as a reference point and the value all measurements were 
compared to. (b) RGDS inhibitor peptide or GRADSP control peptide were added in 2, 100, 
and 250 fold molar excess to PilY1. “*” corresponds to  p<.1 compared to PilY1 binding to 
αVβ5 integrin. (c) PilY1 was added with or without 50 fold molar excess of the inhibitor 
RGDS peptide to 2μg/mL of αVβ3 integrin. “**” corresponds to p<.02 compared to PilY1 
binding to αVβ3 integrin. (d) ∆RGD (∆619-621) or D621A mutations of PilY1 were added to 
2μg/mL of αVβ5 integrin. “***” corresponds to p<.01 compared to PilY1 binding to αVβ5 
integrin. (e) Molar ellipticity values were calculated for the respective wavelength scans and 
compared. 
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Figure 3.3 PilY1 has two functional calcium binding sites. (a) An alignment of the two 
calcium binding sites in PilY1 was done as performed for figure 2. Calcium coordinating 
residues are underlined. (b) D608A, D859A, (c) wild type and D608A/D859A, and (d) D608K 
were modeled to a one-site competition (D608A, D859A, D608K, and wild type), or linear 
line (D608A/D859A). Error represents standard error of the mean. 
 
Figure 3.4. Calcium binding sites play a role in PilY1’s ability binds to integrin. (a) D608A, 
D608K, D859A, D859K (b) D608A/D859A, D608A/D859K, D608K/D859A, and 
D608K/D859K mutations of PilY1 were added to αVβ5 integrin as seen in figure 2B. “*” 
corresponds to p<.01 compared to wild type PilY1 binding to αVβ5 integrin and “**” 
corresponds to p<.1 as compared to wild type PilY1 binding to αVβ5 integrin. (c) represents 
the model of the calcium binding effects on PilY1 binding to integrin. D to A mutations 
represent mutations in the final aspartic acid of the calcium binding site. 
 
Table 3.1. Calcium effects on RGD binding proteins 
 
 
3.8 SUPPLEMENTAL FIGURE LEGENDS 
 
Supplemental Table 3.1 P. aeruginosa PilY1 is homologous to PilC family of bacterial 
adhesin and pilus biogenesis proteins. PilY1 was individually aligned to K. Kingae (Kk) PilC1 
and PilC2, N. gonorrhea (Ng) PilC1 and PilC2, and N. meningitidis (Nm) PilC1 and PilC2 
using http://blast.ncbi.nlm.nih.gov/. C-terminal homology indicates residues that are similar 
(e.g. leucine and isoleucine) while c-terminal identity corresponds to identical residues. 
Strains used for each protein are as follows: ACF19883 for Kingella kingae PilC1, 
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ACF19886.1 for Kingella kingae PilC2, O05924_NEIME for Neisseria meningitidis PilC1 
O05925_NEIME for Neisseria meningitidis PilC2, O05923_NEIGO for Neisseria gonorrhea 
PilC1, and Q51019_NEIGO for Neisseria gonorrhea PilC2.  
 
Supplemental Figure 3.1A-E Circular dichroism for calcium binding mutants. Molar 
ellipticity values were calculated for the respective wavelength scans and compared. 
 
Supplemental Figure 3.2 RGD and calcium binding site mutations binding curves. (a) 
∆RGD and R619A were modeled to one-site binding. (b) Double calcium binding site 
mutants D608A/D859K, D608K/D859A, and D608K/D859K. Error represents standard error 
of the mean 
 
Supplemental Table 3.2 Melting temperatures (TM) for mutations of PilY1. Proteins were 
scanned at 214 nm after an initial CD scan. TMs were calculated using the standard three 
parameter sigmoidal fit. 
 
Supplemental Figure 3.3 Mutational effects on PilY1:Integrin binding. As in Figure 2b-d, 
Wild type PilY1 was established as a reference point and  D608A/D851A/D859A, 
D608A/D855A/D859A, and D608A/D851A/D855A/D859A were measured for integrin 
binding.   
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3.9 ADDITIONAL FIGURE LEGENDS 
Additional Figure 3.1 Isothermal titration calorimetry PilY1.  (a) Wild type or (b) D608A 
PilY1 in the 532-1163. The top panel of each section consists of µcal/sec and the bottom 
panel is Kcal/Mole of Injectant.  
 
Additional Figure 3.2 Mutational effects on PilY1:Integrin binding. As in Figure 2b-d, Wild 
type PilY1 was established as a reference point and  D608A/D621A/D859A was measured 
for integrin binding.   
 
Additional Figure 3.3 The structure of αVβ3 integrin bound to RGD peptide PDB ID 1L5G. 
(a) The αV subunit is highlighted in red, the β5 subunit is highlighted in green, and the RGD 
peptide is highlighted in blue. (b) Same coloring as in A. with the DxDxDG calcium binding 
domain in the αV subunit in magenta and the phenylalanine-tyrosine-tryptophan in cyan. All 
measurements are in angstroms unless otherwise noted. (c) Same coloring as in A and B 
with the PilY1 modled RGD in purple and the PilY1 modeled 600-608 calcium binding loop 
in hot pink. Mn is labeled in green. The αV residue D150 is italicized.  
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Protein Binds calcium Known calcium binding effects
RGD binding integrin 
target(s) [17]
vWF [52] unknown impedes unfolding/protect from cleavage αVβ3 and αIIbβ3 
Thrombospondin [53] yes needed for integrin binding αVβ3 and αIIbβ3 
Fibronectin [49] yes unknown αVβ3, αIIbβ3, αVβ6, αVβ1,  α5β1, and α8β1
Osteopontin [55, 56] yes increased cell adhesion αVβ3, αVβ5, αVβ6, αVβ1,  α5β1, and α8β1
Fibrinogen [50, 52] yes affects folding αVβ3 and αIIbβ3 
Fibrillin [51] yes helps avoid degradation αVβ3
Tenascin [57] unknown activates cell‐adhesion αVβ3 and α8β1
Vitronectin [54] unknown increased cell adhesion αVβ3, αVβ5, α8β1 and αIIbβ3 
Protein 
(residues used)
PilY1 alignment 
residues
C‐terminal 
homology
C‐terminal 
identity
Kingella kingae PilC1 
(620‐1129) 621‐1066 40% 25%
Kingella kingae PilC2 
(890‐1455) 532‐1120 39% 24%
Neisseria meningitidis PilC1 
(470‐910) 595‐1085 40% 27%
Neisseria meningitidis PilC2 
(486‐833) 595‐947 45% 30%
Neisseria gonorrhea  PilC1 
(506‐852) 622‐998 42% 28%
Neisseria gonorrhea  PilC2 
(508‐859) 622‐1000 44% 30%
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73
PilY1 Protein TM (oC)
Wild Type 45.8 ± .2
Chelated Wild Type 44.8 ± .2
D621A (RGA) 44.9 ± .3
Δ619‐621 46.0 ± .3
D608A 44.9 ± .1
Chelated D608A 45.1 ± .2
D608K 45.5 ± .3
Chelated D608K 46.0 ± .4 
D859A 46.1 ± .2
Chelated D859A 45.3 ± .4
D859K 41.8 ± .3
Chelated D859K 43.2 ± .2
D608A/D859A 44.4 ± .4
Chelated D608A/D859A 45.0 ± .3
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Chapter 4 
Kingella kingae PilC1 and PilC2 
 
4.1 Introduction 
Kingella kingae is an anaerobic Gram-negative emerging pathogen mostly involved 
in pediatric infections such as endocarditis, osteomyelitis, septic arthritis, and bacteremia [1]. 
These infections are initiated by attachment of surface bacterial fibers called type IV pili (tfp) 
to host cells. Tfp are essential for a surface walking movement called twitching motility, a 
process necessary for infection. Recently PilY1, in the opportunistic pathogen 
Pseudomonas aeruginosa was shown to use calcium to modulate tfp extension and 
retraction [2]. PilY1 has homologs in numerous other bacteria, such as PilC1 and PilC2 in 
Neisseria meningitidis, Neisseria gonorrhoeae, and K. kingae. In addition to pilus extension 
and retraction, PilCs in N. meningitidis, N. gonorrhoeae, and K. kingae are the organism’s 
respective adhesion proteins [3,4,5]. Presented here are in vitro studies examining the  
calcium binding properties of the tfp associated proteins PilC1 and PilC2 in K. kingae.   
 
4.2 Methods 
PilC constructs and protein purification 
Numerous constructs for PilC1 and PilC2 were examined in various cell lines and 
vectors (Table 4.1). The constructs discussed below produced protein in vitro.  
PilC1 residues 739-1047 were cloned from a pUC vector containing full length PilC1 
into a pMCSG9 LIC HIS MBP vector. Site-directed mutagenesis was performed to produce 
D930A and D930K mutations. Resultant vectors were transformed into BL21 RIPL cells 
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(Stratagene) ampicillin, tetracycline, streptomycin, and chloramphenicol plates overnight and 
a single colony was used to inoculate a 100 mL Luria Broth (LB) flask overnight containing 
50 µg/mL ampicillin, 25 µg/mL tetracycline, 50 µg/mL streptomycin, and 50 µg/mL of 
chloramphenicol. Cell cultures were centrifuged at 3000 x g and the supernatant was 
discarded. The resultant pellet was used to inoculate a 1.5 L shaker flask of Terrific Broth 
(TB) with 50µL of antifoam (Sigma-Aldrich), 50 µg/mL ampicillin, 25 µg/mL tetracycline, 50 
µg/mL streptomycin, and 50 µg/mL chloramphenicol. Cells were grown at 37 oC until OD600 
reached 0.6-0.8. Temperature was reduced to 18 oC and protein expression was induced 
with 0.2 mM IPTG. Cells were grown overnight and harvested by centrifugation 6000 x g at 
for 15 minutes at 4 oC, and pellets were stored at -80 oC. 
Thawed PilC1 pellets were suspended in loading buffer (50 mM sodium phosphate 
pH 7.6, 500 mM NaCl, 25 mM imidazole) supplemented with 0.5 mM EDTA, 0.1% Triton X-
100, 1 mM PMSF, one tablet of a protease inhibitor cocktail (Roche) and 1 ug/ml lysozyme. 
After 1 hour of gently stirring on ice, the cells were sonicated on ice for 1 min and the lysate 
was centrifuged at 45,000 × g for 90 min at 4 oC. Using an ÄKTAxpress™ (GE HealthCare), 
protein from the filtered soluble fraction was nickel purified (Elution buffer consisted of 50 
mM sodium phosphate pH 7.6, 500 mM NaCl, 500 mM imidazole) and purified on an S200 
gel filtration column in the final buffer 20 mM Tris-HCl pH 7.5, 250 mM NaCl, 2 mM DTT, 5% 
Glycerol. Non-degraded protein was then TEV cleaved overnight in a stationary 15 or 50 mL 
tube (Figure 4.1A). TEV cleaved protein was then flowed over Nickel using S200 buffer with 
25 mM imidazole, collected, then purified again over an S200 gel filtration column into S200 
buffer (Figure 4.1B). Protein containing fractions were concentrated, flash frozen in liquid 
nitrogen and stored at -80 oC. 
PilC2 residues 868-1502 (C-terminal fragment) were cloned from genomic K. kingae 
DNA into a pMCSG7 LIC HIS vector. Site-directed mutagenesis was performed to produce 
D1125A, D1125K, D1444A, and D1444K. Resultant vectors were transformed into BL21 
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Gold cells (Stratagene) on ampicillin plates overnight and a single colony was used to 
inoculate a 100mL LB flask overnight containing 50 µg/mL ampicillin. Cell cultures were 
treated as seen above except they were induces with 0.5 mM IPTG. 
Cells pellets were thawed using buffer consisting of 10 mM Tris pH 7.8 and 50 mM 
NaCl as the common buffer base with 10 mM imidazole, DNase and protease inhibitor 
tablets (Roche). Cells were sonicated and cell lysate was separated into soluble and 
insoluble fractions using high-speed centrifugation. The soluble fraction was filtered then 
nickel purified, buffer exchanged, and separated using an S200 gel filtration column on an 
ÄKTAxpress™ (GE HealthCare). If necessary, protein and storage buffers were chelated by 
Chelex-100 to remove bound calcium (Bio-Rad Laboratories). Purified proteins were 
concentrated to ~100 µM, frozen, and stored at -80 oC. 
 
Calcium binding assay 
A binding curve for Oregon Green® 488 BAPTA-5N, hexapotassium salt (Invitrogen) 
in 10 mM Tris pH 7.8 and 50mM NaCl was measured on a PHERAstar (BMGLabtech) at 
488 nm. With 20 µM Oregon Green and 2 µM CaCl2, 868-1502 PilC2 constructs were serial 
diluted 1.5-3 fold from ~100 µM to ~1 nM to obtain an EC50 which was then used to 
calculate the respective Kd for calcium as described previously [2]. 
 
Circular dichroism and thermal denaturation 
Protein samples were exchanged into chelated 10 mM KxHxPO4 50 mM NaF pH 7.7 
buffer and brought to 5 µM with or without the addition of 20 µM CaCl2. A wavelength scan 
from 200-260 λ was performed on a Circular Dichroism Spectrometer 62 DS (Aviv) at 16 oC 
with a 10 second averaging time. Melting temperatures were measures at 214 λ from 3 oC to 
95 oC at one degree increments with a 10 second averaging time. 
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4.3 Results 
4.3.1 Kingella kingae PilC1 and PilC2 Protein Homology 
An NIH BLAST alignment demonstrates that Kingella kingae PilC1 and PilC2 share a 
moderate sequence homology in contrast to PilC1 and PilC2 of N. meningitidis and N. 
gonorrhoeae, which are almost identical [6,7]. Clustal alignment ofthe C-terminal regions of 
PilC1 and PilC2 show that both are more similar to C-terminal P. aeruginosa PilY1 than they 
are to each other (Figure 4.2A and 4.3A) [6,7]. For example, the C-terminal domain of PilC1 
and PilC2 have a 23% / 40% and 22% / 37% identity / similarity to P. aeruginosa PilY1, 
respectively. 
 
4.3.2 PilC1 and PilC2 Calcium Binding 
 K. kingae PilC1 contains a putative calcium binding site located between residues 
922-930 that resembles the sequence of the 851-859 site in P. aeruginosa, PilY1 (Figure 
4.2B). The PilC1-MBP-739-1047 yield was not high enough post-TEV cleavage to conduct a 
calcium binding assay, so fusion protein was used for these assays. PilC1 exhibited a 530 
nM affinity for calcium, which is within the affinity range of previous calcium-binding sites, 
thus confirming that PilC1 binds calcium (Figure 4.4) [Chapter 3 and 5] [2]. 
 The C-terminal region of PilC2 did not contain the PilY1-like calcium binding domain; 
however, upon closer inspection, PilC2 had two putative calmodulin-like calcium binding 
sites at 1114-1125 and 1433-1444 (Figure 4.3B) [8]. Purified PilC2 bound calcium with a Kd 
of 5.5 µM (Figure 4.5A). Mutations in the predicted penultimate calcium binding residues 
were then introduced in an attempt to determine if one or both of these sites bound calcium. 
Mutations to the most calmodulin-like site (D1444A and D1444K) eliminated binding of 
calcium, indicating that only the 1433-1444 site bound calcium (Figure 4.5A). A mutation to 
the predicted penultimate calcium binding residue (D1125K) in the 1114-1125 site confirmed 
this hypothesis by binding calcium to wild type levels (Figure 4.5B, 4.5C).  
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To determine if the mutations to the 1433-1444 site eliminated calcium binding by 
disrupting protein structure, a wavelength scan of wild type and the D1444A mutation 
proteins was performed. There were no significant differences in the spectra of the two 
forms of PilC2 (Figure 4.6A). Also, there was no significant difference between the melting 
temperature of wild type and the D1444A mutant (Figure 4.6B). Taken together, these 
results indicate that mutating the calcium binding residues did not cause a global structural 
change or destabilize the protein. 
  
4.3.3 PilC2 Crystal Trials 
 C-terminal PilC2 had a similar CD spectra and predicted β-propeller fold as C-
terminal fragment of PilY1. To determine more about the PilC class of proteins, C-terminal 
PilC2 was entered into crystal trails in an attempt to solve the protein’s structure (Figure 4.7) 
[2,9,10]. C-terminal PilC2 was mono-dispersed at concentrations up to 15 mg/mL according 
to dynamic light scattering (performed in the UNC Macromolecular Interactions Facility) 
(Figure 4.8). Therefore, C-terminal PilC2 in 10 mM Tris pH 7.8 and 50 mM NaCl was 
examined crystal trials at 7.5 mg/mL after optimal protein concentration was determined by a 
Qiagen prescreen. Screening PilC2 with Classics, classics lite, PEG I, PEG II, PEGrx, 
SaltRx, PEG/ION did not yield any significant results to date.  
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4.4 Figure Legends 
Table 4.1 List of K. kingae PilC1 and PilC2 constructs made 
 
Figure 4.1 SDS PAGE gel of PilC1 739-1047 K. kingae in LIC-HIS-MBP expression (a) 
before TEV cleavage and (b) after cleavage. 
 
Figure 4.2 Homology of PilC1. (a). Homology of the C-terminal regions if K. kingae PilC1 
and P. aeruginosa PilY1 (b). Homology of the C-terminal calcium binding site in K. kingae 
PilC1 
 
Figure 4.3 Homology of PilC2. (a). Homology of the C-terminal regions if K. kingae PilC2 
and P. aeruginosa PilY1 (b). Homology of two putative C-terminal calcium binding sites in K. 
kingae PilC2 and calmodulin’s consensus calcium binding site. 
 
Figure 4.4 K. kingae PilC1 binds calcium.  
 
Figure 4.5 K. kingae PilC2 has one functional calcium binding site. (a) A wild type binding 
curve was tested in concert with two mutants (D1444A and D1444K) to determine if one, 
both or none of the putative calcium binding sites were real. (b) An additional mutant was 
made to test the remaining putative calcium binding site. (c) Homology showing that there is 
one confirmed C-terminal calcium binding sites in K. kingae PilC2 and calmodulin’s 
consensus calcium binding site. 
 
Figure 4.6 Stability of PilC2 D1444A mutants via (a) a circular dichroism wavelength scan 
and (b) and by determining the thermal melting temperature. 
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Figure 4.7 Comparison of C-terminal PilC2 and 532-1163 P. aeruginosa PilY1 by circular 
dichroism wavelength scan. 
 
Figure 4.8 Dynamic light scattering of C-terminal PilC2 at (a) 10 mg/ml and (b) 15 mg/ml 
 
 
 
Construct BL21  BL21 RIPL
Kk PilC1
1 34‐465 ‐ ‐
2 521‐1047 ‐ ‐
3 540‐end ‐ ‐
4 739‐1047 ‐ ‐
5 739‐1047 MPB ‐ +
6 540‐1047 ‐ ‐
7 822‐1022 CPD ‐ ‐
8 848‐1022 CPD ‐ ‐
9 822‐1042 CPD ‐ ‐
10 848‐1042 CPD ‐ ‐
Kk PilC2
1 36‐840 ‐ ‐
2 868‐1502 ++++ N/A
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Chapter 5 
Effects of Calcium Binding on the Neisseria gonorrhoeae adhesin, PilC1 
 
5.1 Summary 
 PilC1, a type IV pilus adhesion protein in the infectious bacterium, Neisseria 
gonorrhoeae, is a member of the PilC1-like family of adhesins found in other Neisseria 
speciesand Pseudomonas genera. Previous attempts to characterize the role of N. 
gonorrhoeae PilC’s role in adhesion have been hampered by the inability to produce 
significant amounts of protein. Here, we define a method to produce recombinant full length 
PilC1 and demonstrate that this protein can inhibit N. gonorrhoeae binding to mammalian 
cells. In adition to adhesion, PilC1-like proteins also control pilus biogenesis. Recently, the 
PilC1-like protein PilY1 from Pseudomonas aeruginosa was shown to control pilus 
biogenesis through a C-terminal calcium binding site. Calcium-bound and -unbound states 
of PilY1 control pilus extension and retraction, respectively. We have identified a 
homologous calcium binding site in the C-terminal half of N. gonorrhoeae PilC1. Moreover, 
we show that the PilC1 calcium binding site mediates adhesion though regulating functional 
pilus biogenesis. Taken together, we establish that ion binding plays a critical role in PilC1 
function. 
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5.2 Introduction 
Neisseria gonorrhoeae is a Gram-negative bacterium that causes the sexually-
transmitted disease gonorrhea and a variety of inflammation based human diseases. 
According to the CDC, there were more than 300,000 U.S. cases of gonorrhea reported in 
2009. Typical N. gonorrhoeae infections are initiated by attachment to human epithelial 
cells. Adhesion is mediated by type IV pili (tfp) extended from the bacterial surface [1]. Once 
tfp contact is made, N. gonorrhoeae uses other surface machinery to solidify host 
attachment as it initiates invasion of epithelial cells [2]. N. gonorrhoeae tfp are polymeric 
structures predominately composed of the major pilin protein, PilE [3]. Tfp are also found in 
Pseudomonas aeruginosa, Ralstonia solanacearum, Xylella fastidiosa, and other Neisseria 
species [4]. In addition to colonizing host cells, tfp are essential for many other bacterial 
activities, such as twitching motility, DNA uptake, DNA conjugation, and biofilm formation 
[5,6].  
Disruption of tfp biogenesis in N. gonorrhoeae is associated with abated virulence, 
likely due to a reduction in initial adhesion [7]. The 110 kDa N. gonorrhoeae PilC protein was 
first identified as a tfp-tip-associated adhesin and later shown to be associated with the 
outer-membrane of N. gonorrhoeae [8,9]. N. gonorrhoeae has two similar and functionally 
interchangeable PilC genes in its genome, PilC1 and PilC2 [10]. PilC1 purified from N. 
gonorrhoeae blocks bacterial adherence to human epithelial cells [11] . Furthermore, the N-
terminal region of PilC was found to be responsible for the binding interaction [10]. Several 
experiments have suggested that the initial adherence of N. gonorrhoeae to human cells is 
facilitated by the human complement cell receptor CD46; however, there is evidence that 
attachment is CD46-independent [12,13,14]. Previously, the yield of purified PilC1 has been 
too low to meet the requirement of extensive in vitro studies. In this work, we have 
developed a new expression and purification method for PilC1 that is significantly more 
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efficient than previous methods. PilC is also involved in functional pilus biogenesis as with 
homologous proteins in other organisms such as P. aeruginosa, PilY1 [15,16]. Functional P. 
aeruginosa pilus biogenesis is dependent on PilY1 binding calcium; calcium bound and 
unbound forms corresponding to pilus extension and retraction, respectively [15]. Similarly, 
we have identified a PilY1-like calcium binding site in the C-terminal region of PilC1 and 
examined its role in N. gonorrhoeae.    
 
5.3 MATERIALS AND METHODS 
Protein constructs, expression and purification  
Standard ligation independent cloning techniques, as described by Stols et al. [17], 
were employed in the construction of expression plasmids encoding the segments of PilC1 
used in this study. Amplified DNA fragments, full-length (FL) PilC1 (residues 23-1037) and 
the C-terminal domain (CTD) of PilC1 (residues 519-1037), were treated and cloned into an 
empty pMCSG7-Lic-His expression vector.  All expression plasmids used in this study were 
sequence verified. 
Expression plasmids were transformed into E. coli BL21(DE3) Origami 2 cells 
(Stratagene). Bacteria were grown in LB medium supplemented with ampicillin, streptomycin 
and tetracycline at 37 oC with shaking. After the OD600 reached 0.6, isopropyl β-D-
thiogalactoside was added to a final concentration of 0.2 mM and bacteria were grown for 
another 12 hours at 16 oC with shaking after which the bacteria were harvested, pelleted 
and stored at -80 oC. Pelleted bacteria thawed on ice were resuspended in loading buffer 
(50 mM NaxHxPO4 pH 7.6, 500 mM NaCl, 25 mM imidazole) supplemented with 0.5 mM 
EDTA, 0.1% Triton X-100, 1 mM PMSF, one tablet of a protease inhibitor cocktail (Roche) 
and 1 ug/ml lysozyme. After 1 hour of gently stirring on ice, cells were sonicated on ice for 1 
109 
min and the lysate was centrifuged at 45,000 × g for 90 min at 4 oC. Using an ÄKTAxpress™ 
(GE HealthCare), protein from the filtered soluble fraction was nickel column purified using 
elution buffer consisting of 50 mM NaxHxPO4 pH 7.6, 500 mM NaCl, 500 mM imidazole, and 
purified on a S200 gel filtration column (GE Healthcare) in 20 mM Tris-HCl pH 7.5, 250 mM 
NaCl, 2 mM DTT, 5% glycerol. Protein containing fractions were concentrated, flash frozen 
in liquid nitrogen and stored at -80 oC.  Purified protein was >95% pure by SDS-PAGE.  
Calcium binding assay 
Terbium ions were used as a substitute for calcium ion due to their similar ionic 
radius and coordination properties. Förster resonance energy transfer (FRET) was carried 
out at 25 oC using a SPEX Fluorolog-3 Research T-format Spectrofluorometer (Horiba Jobin 
Yvon, Edison, NJ). Terbium chloride was diluted in 20 mM Tris-HCl, pH 7.5, 250 mM NaCl to 
a working concentration of 10 mM. Protein (400 μl at 0.2 mg/ml) was added to the cuvette, 
and terbium chloride was added in 0.2 μl increments. Intrinsic tryptophan fluorescence was 
used to excite the protein sample at 283 nm, and terbium fluorescence emission was 
recorded at 543 nm. The error bars represent the standard deviation of three replicates. The 
data was fitted to a one-site binding equation.  
Circular dichroism spectroscopy 
Far-UV CD spectra of wild type C-terminal PilC1 and mutants D731A, D733A, and 
D739A were measured with a Chirascan™ Circular Dichroism Spectrometer (Applied 
Photophysics) from 205-260 nm using a 1 mm path-length cell at 22 oC. Thermal 
denaturation of PilC1 was analyzed by monitoring ellipticity changes at 216 nm while the 
sample was heated at a constant rate from 10 to 80 oC.  The basic protein buffer contained 
25 mM HEPES, pH 7.5 and 150 mM NaF.    
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Cell lines and growth conditions 
ME180 cells were grown in McCoy’s 5A medium supplemented with 10% fetal 
bovine serum (FBS) at 37 oC, 5% CO2. N. gonorrhoeae strains were grown on GCB-agar 
plates, containing Kellogg’s supplement [18] at 37 oC in 5% CO2. 
Recombinant expression of PilC in N. gonorrhoeae 
 This method can be found in the Chris Thomas lab where the experiments were 
performed. Each western was band was quantified using NIH ImageJ software [19]. Each 
band was placed in the same size tight rectangle and was compared to the wild type PilC1 
band that was normalized to 1. 
Cell adherence assay 
Cell adherence assays were performed as previously described [14] except the 
human epithelial ME180 cell line was employed. In necessary experiments, ME180 cells 
were pre-incubated with different concentrations of full-length PilC1 protein (residues 23-
1037) or PilC1-CTD (residues 519-1037). ME180 cells were then incubated with the 
appropriate N. gonorrhoeae strain. After one hour, ME180 cells were washed three times 
with medium and lysed with 1% saponin. Colony forming units were quantified by plating 
serial dilutions of ME180 cell lysates. The assay was performed in triplicate and the error 
bars represent standard error of the normalized fraction of N. gonorrhoeae adherence or 
percent inhibition.  
Cell surface exposure assay 
Purified PilC1 specific monoclonal antibody, 4B5.10, was biotinylated with NHS-
PEO4-Biotin. It was incubated with appropriate Neisseria gonorrhoeae strains for 30 min 
and bound antibody was detected by binding of HRP-streptavidin. HRP was then detected 
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by production of light in the presence of a chemiluminescent substrate. All experiments were 
done in triplicate.   
Aggregation of N. gonorrhoeae 
N. gonorrhoeae strains were grown at 37 oC overnight on GCB-agar plate. Bacteria 
were scraped off and resuspended in PBS buffer to OD600 ≈1. The suspension was kept at 
room temperature and the OD600 of the supernatant was measured at different time-points.  
Transformation Frequency 
 This method can be found in the Chris Thomas lab where the experiments were 
performed.  
 
5.4 RESULTS 
5.4.1 Obtaining Soluble Recombinant Protein 
To identify PilC1 constructs that can be expressed as soluble proteins in E. coli, we 
test-expressed a series of PilC1 constructs in numerous E. coli cell lines. Our results show 
that full-length (FL) PilC1 (residues 23-1037) and the C-terminal domain (CTD) of PilC1 
(residues 519-1037) can be expressed as soluble proteins in E. coli BL21 (DE3) Origami 2 
cells. SDS-PAGE showed that the purity of purified FL-PilC1 and PilC1-CTD was over 95% 
(Figure 5.1A). The expression level of PilC1-CTD is considerably higher than that of FL-
PilC1. Similarly, the final obtainable concentration was more than 100 µM (>10mg/mL) for 
PilC1-CTD versus 0.66 µM (0.76 mg/mL) for FL-PilC1. Accordingly, these two PilC1 
constructs were used in the following in vitro studies of PilC1.  
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5.4.2 Recombinant FL-PilC1 blocks N. gonorrhoeae Binding  
Previous studies showed that purified FL-PilC1 can block the adherence of N. 
gonorrhoeae to human cells by competing with pilus-associated native PilC1 [11]. Here, we 
examined the impact of the recombinant proteins FL-PilC1 and PilC1-CTD on the adherence 
of N. gonorrhoeae strain FA1090 to human ME180 cells. FL-PilC1 inhibited the adherence 
in a dose-dependent manner with an IC50 in the low- to mid-nanomolar range (Figure 5.1B). 
As expected, our results also showed that PilC1-CTD did not affect the adherence of N. 
gonorrhoeae to human ME180 cells (Figure 5.1B). Taken together, our results suggest that 
the recombinant FL-PilC1 obtained in this study is likely well folded and able to mimic in vivo 
expressed PilC1.  
 
5.4.3 Calcium Binding Domain Homology 
Recent studies have identified a calcium binding site in the Pseudomonas 
aeruginosa protein, PilY1, which shares a high degree of homology with the PilC protein 
from N. gonorrhoeae [15]. Sequence alignment suggests that N. gonorrhoeae PilC1 also 
has the calcium binding site in the CTD (Table 5.1). We sought to determine if PilC1-CTD 
binds calcium and what specific residues are involved in binding. Calcium binding 
experiments showed that PilC1-CTD binds calcium in a manner that can be fitted with a one-
site binding model (Kd = 0.9 ± 0.2 µM) (Figure 5.2A). Moreover, mutations of the putative 
calcium binding site aspartic acid residues to alanines (D731A, D733A and D739A) 
eliminate the ability of PilC1 to bind calcium (Figure 5.2A). Thus, we have both confirmed 
that PilC1 binds calcium and that the chelating residues include D731, D733, and D739.  
It is possible that we disrupted the native protein folding state by making the aspartic 
acid to alanine mutations, thereby rendering the PilC1-CTD protein unable to bind to 
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calcium. The impact of these mutations on the secondary structure of PilC1-CTD was 
examined by circular dichroism (CD) spectroscopy. We saw no shift in the CD profile with 
any of the mutants as compared to calcium bound wild type PilC1-CTD, indicating that the 
mutations did not disrupt the global secondary structure of the protein (Figure 5.2B). 
Furthermore, we did not observe a CD profile difference between chelated and calcium-
bound forms of wild type PilC1-CTD (Figure 5.2B). We also investigated the thermostability 
of the calcium binding domain mutations and chelated wild type PilC1-CTD as compared to 
calcium bound wild type PilC1-CTD. We found no significant difference in the melting 
temperature (Tm) between all forms of PilC1-CTD (Table 5.2). Taken together, these results 
show that mutations to the PilC1 calcium binding site do not change the proteins’ overall 
secondary structure or stability. 
 
5.4.4 Expression of Calcium Binding Mutants in N. gonorrhoeae 
To examine the role calcium binding plays in the function of PilC1 in vivo, we 
engineered several N. gonorrhoeae strains in strain FA1090, which has the pilC2 gene out 
of frame and therefore no PilC2 expression. We substituted the wild type pilC1 gene with 
pilC1 genes that carried different calcium binding site mutations. We first examined the 
expression of PilC1 mutants in engineered N. gonorrhoeae strains. Western-blot analysis 
showed that PilC1-D731A had wild-type level expression, while for unclear reasons, PilC1-
D733A and PilC1-D739A had reduced expression (Figure 5.3). As a result, only the PilC1-
D731A calcium binding mutant was used in the remaining studies.  
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5.4.5 Mutations to the Calcium Binding Site Reduce Surface PilC1 and ME180 
Adherence 
 We next investigated the exposure of PilC1 mutants on the surface of N. 
gonorrhoeae. The monoclonal antibody 4B5.10 can recognize pilus-associated and outer-
membrane associated PilC1. As expected, the non-piliated N. gonorrhoeae strain 
(PilC1+/∆PilE) was used as a negative control. Our results showed that the amount of PilC1-
D731A on the bacterial surface was significantly reduced relative to wild-type PilC1 (Figure 
5.4), suggesting that calcium binding promotes trafficking of PilC1 to the cell surface. In 
addition, the N. gonorrhoeae strain expressing PilC1-D731A exhibited dramatically reduced 
adherence to human ME180 cells compared to the N. gonorrhoeae strain expressing wild-
type PilC1 (Figure 5.5). Together, these results indicate that the PilC1 calcium binding site 
impacts adhesion possibly by controlling type IV piliation. 
 
5.4.6 PilC1 Calcium Binding Site Affects Aggregation and Transformation Frequency 
To confirm that the calcium binding site affected pilus biogenesis, we examined two 
N. gonorrhoeae pilus dependent processes, aggregation and transformation frequency 
[20,21]. As expected, the pilus retraction deficient strain (PilC1+/∆PilT) and the piliated strain 
(PilC1+) displayed higher levels of aggregation than the non-piliated N. gonorrhoeae strain 
(PilC1+/ ∆PilE), which displayed the lowest levels (Figure 5.6A) [21]. The strain expressing 
PilC1-D731A displayed similar levels of aggregation as the non-piliated strain, suggesting 
that it exhibits defects in pilus biogenesis, consistent with PilY1 data from P. aeruginosa 
(Figure 5.6A) [15].  
We examined the transformation frequency of the aforementioned strains of N. 
gonorrhoeae. Recall that transformation frequency is highly dependent on functional pilus 
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biogenesis [21]. Accordingly, the pilus retraction deficient strain (PilC1+ /∆PilT) and the non-
piliated strain (PilC1+/ ∆PilE) had non-detectable levels of transformation, while the piliated 
strain (PilC1+) had functional levels of transformation efficiency (Figure 5.6B). The calcium 
binding deficient PilC1-D731A strain had significantly less competence than the piliated 
strain (Figure 5.6B). Thus, the calcium binding site in PilC1 appears to control functional 
pilus biogenesis.  
5.5 DISCUSSION 
N. gonorrhoeae is well established as a sexually transmitted pathogen and the cause 
of numerous inflammatory diseases, such as pharyngitis, endocarditis, and pelvic 
inflammatory disease [22,23]. Because adhesion though a functional tfp is a necessary step 
for infection, we sought to understand more about this process [3]. The focus of this study 
was the N. gonorrhoeae tfp adhesion protein, PilC1. Here, we define a new purification 
method for recombinant full length and C-terminal PilC1. Using these recombinant proteins, 
we confirmed that the adhesion domain of PilC1 was in the N-terminal region and that 
purified FL-PilC1 could be used as a competitive inhibitor of N. gonorrhoeae binding to 
ME180 cells. The method defined here to successfully express and purify both recombinant 
full-length and C-terminal PilC1 will prove beneficial in determining the specific PilC1 N-
terminal domain residues responsible for adhesion and characterizing the resultant host cell 
binding interaction. 
We also characterized a calcium binding site at residues 701-709 in N. gonorrhoeae 
PilC1.  Based on the conserved PilY1 calcium binding site, we identified the residues within 
this site responsible for calcium chelation and showed that eliminating the ability for this site 
to bind calcium abolished adhesion by preventing surface piliation. As previously mentioned, 
PilY1’s 851-859 calcium binding site controls pilus extension and retraction [15]. This 
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calcium binding site is not only conserved in N. gonorrhoeae PilC2, but in a variety of tfp 
containing bacteria (Table 5.1).  
Tfp are used for a variety of cellular processes including motility, DNA uptake and 
adhesion-mediated infection [3]. Here, we continue to expound upon the importance of 
calcium binding sites in the PilC family of proteins. Although the mechanism by which these 
calcium binding sites control pilus biogenesis is unclear, we are beginning to extend the 
calcium bound and unbound model for the PilC family of proteins to control pilus extension 
and retraction, respectively.  
Future work will include using purified 731A-FL-PilC1 to attempt to block N. 
gonorrhoeae from binding to ME180 cells. Given that the PilC1 binding domain is N-terminal 
and the calcium binding site is in the C-terminal region of the protein, we expect that purified 
731A-FL-PilC1 will produce the same results as wild type protein in eliminating N. 
gonorrhoeae’s ability to bind to ME180 cells. Preliminary results suggest this hypothesis is 
correct. 
 
117 
5.7 Figure Legends 
Figure 5.1 Purified full-length PilC1 protein inhibits in a dose-dependent manner the 
adherence of Neisseria gonorrhoeae to human epithelial cells.  (A) Full-length (FL) 
PilC1 (residues 23-1037) and the C-terminal domain (CTD) of PilC1 (residues 519-1037). 
(B) ME180 cells were preincubated with increasing concentrations of PilC1 proteins for 30 
minutes before being washed and incubated with N. gonorrhoeae strain FA1090 in our cell 
adherence assay. The assay was performed in triplicate on three days. The error bars 
represent the standard error of the normalized fraction of N. gonorrhoeae adherence.  
 
Table 5.1 Partial sequence alignment of calcium binding for various tfp containing 
species. Numbers correspond to residues in PilC1 Neisseria gonorrhoeae FA1090. 
Underlined bolded residues correspond to conserved calcium binding site. Predicted amino 
acid sequence in this region is identical in 9 of the 11 available gonococcal PilC sequences 
and 23 of the 30 N. meningitidis sequences. Exact matches in sequence are highlighted in 
blue and by a “*” at the bottom of the alignment, green and “:“ indicate strongly conserved 
residue, and violet and “.” Indicates weakly conserved residues. 
 
Figure 5.2 Binding of Tb3+ to different PilC1 constructs. (A) Different PilC1-CTD 
constructs were titrated with increasing concentrations of TbCl3 as described in our materials 
and methods. The solid line is computer fit of the data using one-site binding model. (B)  
The far-UV CD spectra of PilC1-CTD in the absence or presence of CaCl2  were recorded as 
described in the materials and methods.  
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Table 5.2 Impact of calcium binding on the thermostability of PilC1. The change of 
ellipticity at 216 nm with the increase of temperature was recorded as described in the 
materials and methods. The melting temperature (Tm) indicates the temperature that the 
protein loses half of its ellipticity at 222 nm.   
 
Figure 5.3 Expression of PilC1 calcium binding mutants in N. gonorrhoeae. Western-
blot of the whole cell lysates of N. gonorrhoeae strains expressing different PilC constructs 
are shown here. N represents the N. gonorrhoeae strain that does not express PilC.   
 
Figure 5.4 Impact of calcium binding on the surface exposure of PilC1 in N. 
gonorrhoeae. The surface exposure of PilC1 proteins and the adherence of different N. 
gonorrhoeae strains to human ME180 cells were performed as described in the materials 
and methods. The experiments were performed in triplicate on three days. The error bars 
represent the standard error of the normalized fraction of surface exposure or N. 
gonorrhoeae adherence.  
 
Figure 5.5 Impact of calcium binding on the adherence of N. gonorrhoeae to human 
ME180 cells. D709A PilC1 mutation results in a significant reduction in adherence to 
ME180 epithelial cells in vitro.  The percentage of adherent N. gonorrhea challenge 
inoculum preparation to epithelial cells was calculated and plotted from triplicate replicates 
in four separate experiments conducted on four successive days. Data are expressed as the 
mean and standard deviation.  Data was compared by Repeated Measures ANOVA and 
Tukey analysis (P=0.0001).   
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Figure 5.6 Impact of calcium binding on aggregation and transformation frequency in 
N. gonorrhoeae. (A) Four ml cultures of strains 7474, 7477, 7489 and 7495 were allowed to 
settle over a 300 minute time course, with an OD reading taken every 50 minutes.  Results 
starred showed significance of p< 0.05 by 2-way ANOVA.  Differences between strains 7474 
and 7477, strains 7489 and 7495, and strains 7489 and 7477 were significant (p< 0.05) by 
Tukey's Multiple Comparison Test. (B) D709A PilC1 expressing N. gonorrhea are less 
competent than WT PilC1 expressing N. gonorrhea. Results are expressed as percentages 
of recipient cells transformed described as a ratio to the wt control. Data are expressed as 
the means and standard deviations from 3 independent experiments.  Data was analyzed by 
Repeated Measures ANOVA and Tukey analysis.  (P=0.0001)  
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PilC1 Protein Tm
WT + 10 µM CaCl2 46.28 ± 0.10
WT no CaCl2 46.17 ± 0.18
D701A 46.32 ± 0.11
D703A 47.15 ± 0.16
D709A 46.59 ± 0.19
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CHAPTER 6 
Past and Future Studies of Pseudomonas aeruginosa PilY1, PilY2, and  
Neisseria gonorrhea PilC1 
 
6.1 Introduction 
 There are a number of characterization studies that were performed using 
Pseudomonas aeruginosa PilY1 and PilY2 both in vitro and in the organism that did not 
make into publications. These experiments include, but are not limited to, crystallization 
studies, binding experiments, and twitching assays. In addition, a number of future 
experiments are outlined for both Pseudomonas aeruginosa PilY1 and Neisseria gonorrhea 
PilC1. 
 
6.2 Pseudomonas aeruginosa PilY1  
6.2.1 PilY1 Purification 
 There were many constructs that were made in an attempt to get the full length or N-
terminal construct of PilY1 (Table 6.1). The vectors included were in the pMCSG18 LIC-HIS 
vector, pET 22b(+) containing the periplasmic targeting leader sequence, pelB. There were 
many reasons for trying to get this protein such as for a potential crystallization target. There 
were also a variety of cells lines that each construct was tired in (Table 6.1). One goal would 
be to insert the protein in crystal trials in an attempt to elucidate the atomic structure of the 
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full protein. Viewing the intramolecular interactions is important for understanding other 
possible functions of PilY1, specifically how it might interact with the membrane or pilus. Of 
the additional constructs made after the two listed previously in this dissertation (615-1163 
and 532-1163), six other constructs expressed, but were shorter than the 532 construct, 
while one longer construct weakly expressed (354-1163) with the pelB leader sequence. 
The 354-1163 construct degraded however, and was mostly soluble aggregate. 
 
6.2.2 PilY1 Crystallization 
 A number of screens were conducted for the 532-1163 (mostly in the buffer 10mM 
Tris pH 7.8 50mM NaCl) at 10 mg/mL. Protein was mono-disperse up to 15 mg/mL (Figure 
6.1). Screens included Morpheus, Classics, classics lite, PEG I, PEG II, PEGrx, SaltRx, 
PEG/ION, JCSG+, and JCSG1-4. 532-1163 PilY1 was also sent to the Hauptman-
Woodward Institute. The best crystal hit appeared in 9 days at 16oC was in the PEG II 
screen condition H6 (100mM Tris pH 8.5 8% PEG 8000) (Figure 6.2). However, the 
observed molecular weight of these crystals as determined by SDS page gel was degraded 
to ~48 kD, the same size seen in the trypsin limited proteolysis (Figure 6.3A, B). This 
represented the possible beginning site of the domain swap from C-terminal structure 
(residues 721-726); thus, constructs were designed to reflect both of these starting points 
[1]. Future crystallization trials with one of these constructs have yet to be conducted; even 
so, these constructs would most likely yield no new structural data. 
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6.2.3 PilY1 Metal Binding 
 Calcium and manganese can have the same coordination and thus, in some cases, 
these two elements can bind in the same location. This phenomenon is most evident in the 
αVβ3 structures, consensus calcium binding sites can bind to both calcium and manganese 
[2,3]. Therefore, we wanted to test PilY1’s ability to bind manganes. To accomplish this goal, 
we first made sure the Oregon Green fluorescent chelater would bind to manganese, to 
which it did with a Kd of 3 µM, thus binding better than it does to calcium (Figure 6.4A).  We 
then used the 615-1163 construct of PilY1 to test the manganese binding affinity of the 851-
859 site. We measured a Kd of 5 µM, thus, we confirmed that these site indeed binds 
manganese and that said binding is roughly two-fold lower than to calcium (Figure 6.4B) [1]. 
 
6.2.4 RGD mutations in PAK PilY1 in vivo assays 
 R619A (AGD) and D621A (RGA) mutations were made in the PAK strain of PilY1 
using the process described in chapter 2 [1]. Before testing the adherence of these bacteria 
to transformed cell lines, it was necessary to measure if other common bacterial attributes 
were affected. The first question was if the mutants would make wild type levels of PilY1 
expressed in P. aeruginosa. Wild type levels of mutant PilY1 were expressed at 50 μM IPTG 
consistent with the expressed wild type protein (Figure 6.5). Recall that PilY1 was deleted 
from P. aeruginosa, and added back via the same method as the mutants were added 
(PilY1+). 
 The next things to test for were how the mutations affected twitching motility and 
surface piliation. Both methods were performed as in Chapter 2 [1]. Twitching motility 
between the aforementioned strains was also statistically similar indicating that the RGD 
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mutations had the same overall motility (Figure 6.6A). Also, the amount of PilA made in the 
R619A and D621A mutations was consistent with the PilY1+ strain (Figure 6.6B).  
 Finally, the mutations were tested for adherence versus HeLa cells. A monolayer of 
HeLa cells were grown in a 24 well dish using standard HeLa cell culturing practices. PilY1+, 
PilY1-, AGD, and RGA strains of P. aeruginosa at O.D. .08 or just media with no bacteria 
were incubated with the HeLa cells with the appropriate amount of IPTG for 1 hour. Wells 
were then washed with PBS 3 times, serial diluted, and plated. The diluted inoculum was 
also plated for a method of comparison. The PilY1+ bound to roughly 11% of the inoculum, 
which is consistent with previous reports involving wild type PilY1 and HeLa cells (Figure 
6.7) [4]. The PilY1- strain was close to 0% as expected (Figure 6.7). Mutating the aspartic 
acid drastically reduced the adhesion by almost an order of magnitude whereas the AGD 
mutation seemed to have very little effect (Figure 6.7). As in Chapter 3, the aspartic acid of 
the RGD is absolutely necessary for integrin binding. Previously published reports suggest 
that the arginine might not be as necessary for adhesion, explaining why adhesion was seen 
in this experiment [5,6]. Perhaps the AGD mutant conveyed a small amount of binding and 
the cells were saturated, hence no amount of dilutions post collection would have shown 
less binding. If the previous hypothesis is correct, one could use a smaller amount of 
bacteria as the original inoculum to detect a better difference between the PilY1+ and the 
AGD mutation. 
 Adding these mutations (or the calcium binding site mutations) to the chromosome 
would also be advantageous. As such, they were added to PAK, but these new strains 
ability to produce intracellular PilA and PilY1 were not consistent with wild type PAK. 
Interestingly, in making each mutation, half of the crosses were not successful in that they 
still contained the wild type PilY1, yet, they had the same morphology of the mutations, not 
the wild type PAK. Therefore, these new strains could be used as attenuated forms of PAK 
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and inserted into various adhesion assays, contingent upon making consistent amounts of 
PilY1 and PilA. Ideally, these strains would be used in animal models to test for infection 
rates. Two interesting models of note would be in the burn wound mouse model or the CF 
mouse model [7]. Also interesting would be to add these mutations to a GFP P. aeruginosa 
and look for infection of transparent organism (that have the required integrins) such as 
zebrafish [8].  
 
6.2.5 Potential PilY1 Small Molecule Inhibitor Assay 
 PilY1 calcium binding is necessary for functional pilus biogenesis [1]. Thus, 
eliminating the ability of PilY1 to bind calcium would yield a potential therapeutic approach. 
The best way to identify a small molecule inhibitor is through high-throughput screen. For 
this experiment, there are three essential components: the protein, calcium, and something 
to detect calcium binding.  
Ideally, this experiment would be based on the calcium binding curve seen in 
Chapter 2 Figure 2.2D, where the calcium binding affinity of 615-1163 PilY1. Recall that in 
this experiment, Oregon Green was kept at 20 µM, the PilY1 concentration was titrated, and 
the calcium chloride concentration was kept 2 µM, thus leading to the competition over 
calcium. The PilY1 amount would be added at the EC50 of 3.2 µM (Figure 6.8A). Small 
molecules would be added to each well to detect a change in fluorescence (Figure 6.8B). 
The optimal solution would be a compound that sterically blocks calcium from 
binding to PilY1 (Figure 6.8B). This result would be indicated with an increase in 
fluorescence implying the Oregon Green is binding more calcium in solution. A potential 
pitfall would be that the compound is a calcium or general metal chelator and the readout 
would show that there is no fluorescence (Figure 6.8B). Consequently, this fluorescence 
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could also mean that the compound caused PilY1 to bind calcium tighter. This scenario 
could also be an acceptable solution because the bacteria would not be able to twitch due to 
essentially having “dead legs” [1]. 
 
6.2.6 PilY1 H797 Mutation 
 A conserved histidine within P. aeruginosa at position 797 in PAK PilY1 makes a 
hydrogen bond with D859 (Figure 6.9) [1]. As can be seen in Chapter 2, this histidine is also 
conserved in N. gonorrhoeae. Without calcium bound, the residues of the 851-859 CBS 
could sterically force the histidine to interfere with the beta-propeller or the α-helix 6. A 
H797A mutation of this amino acid has been made in PilY1 but has yet to be tested. 
Analysis of how this mutation affects calcium binding, twitching motility and extracellular 
pilus production may yield new insight into how calcium mediates functional pilus 
biogenesis. Specifically, it may begin to provide evidence of the small structural changes 
that occur when PilY1 binds calcium. 
 
6.2.7 P. aeruginosa Biofilm Formation in the Presence of Host Cells 
 Bacterial biofilm formation is a measure of how these organisms can sense each 
other in their environment. Functional biofilm development is tfp-dependent [9]. The sugar 
subunit of biofilms can be stained using Alcian Blue for detection; crystal violet can be used 
to stain the bacteria [10]. Glass slides will be inoculated and fixed after 18 hours, washed 
and stained with the aforementioned dyes for detection of bacteria and biofilms [10]. 
Because the RGD and proximal calcium mutations do not affect piliation or twitching, these 
strains are expected to produce wild type morphology and levels of biofilm. 
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6.2.8 Exotoxin Secretion 
 Bacterial exotoxin production can be used as a measure of how bacteria perceive 
their environment, specifically detection of host cells. Using wild type PAK, a baseline level 
of exotoxin A and exoenzyme S can be measure by examining the media of the growing 
bacteria without host cell stimuli. Once the baseline is established, P. aeruginosa with 
detrimental and calcium mimicking mutations in one or both sites will be measured for toxin 
production and secretion with and without host cell stimuli. The amount of exotoxin A and 
exoenzyme S will be ascertained via western blot analysis across several time points 
(sigma-aldrich and abcam respectively). A fold increase will be measured in the presence of 
host cell stimuli, which will then be normalized to the amount of bacteria added, and shown 
as percent increase (or decrease) in secreted virulence factors. The mutants tested would 
be the proximal calcium binding site mutants, D608A and D608K, and the RGD mutations. It 
is expected that the only mutation that gives wild type levels of toxin secretion will be the 
D608K mutation. Recall that in a the D859A mutation, the tfp would never make it out the 
cell to bind. 
 
6.2.9 Host Cell Viability 
 Another measure of bacterial pathogenicity is the ability to infect and/or kill host cells. 
In this experiment, human corneal and lung epithelial cells will be inoculated with P. 
aeruginosa containing PilY1 with point mutations in the Ca2+ binding domain or of the 
surrounding area. After multiple time points, cell samples will be stained with annexin V, an 
antibody for apoptosis (BD biosciences), and examined using flow cytometry. These results 
should be consistent with the toxin screen results. 
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6.3 Pseudomonas aeruginosa PilY2 
6.3.1 PilY2 Expression 
PilY2 is an 114 amino acid 15 kD protein that is in the fimU-pilVWXY1Y2E operon 
that is regulated by AlgR in P. aeruginosa thought to play a role in fimbrial biogenesis [11]. 
Because pilY2 is directly downstream pilY1 in the operon and therefore in theory co-
expressed with PilY1, it was thought that PilY2 could be a potential binding partner. 
Therefore we sought to purify the full length PilY2 from the PAK strain of P. aeruginosa. 
Cloning in the pMCSG18 LIC-HIS vector, we were able to solubly express full length PilY2, 
including the predicted signal peptide from residues 1-18 (Figure 6.10A) [12]. PilY2 
appeared to be well folded mix of α-helicies and β-sheets with no significant traces of 
random coil on CD (Figure 6.11).  
 
6.3.2 PilY2 Binding Experiments 
We added 532-1163 PilY1 and full length PilY2 in a mixture and attempted to co-
elute the proteins on a sizing column. Results show that there was no binding between the 
two proteins (Figure 6.10B). It is possible that these proteins do interact, but in the N-
terminal domain only. Such experiments are difficult due to the insolubility problems of N-
terminal PilY1. Binding experiments with 354-1163 PilY1 have not been tried, nor has any 
other direct binding assay. 
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6.3.3 PilY2 Crystallization Trials 
PilY2 at 10 mg/mL in 10mM Tris pH 7.8 and 50mM NaCl was also included in crystal 
trials using Classics, classics lite, PEG I, PEG II, PEGrx, SaltRx, PEG/ION screens. No 
significant hits were observed. 
 
6.4 Neisseria gonorrhoeae PilC1 
6.4.1 Putative Neisseria gonorrhoeae PilC1 calcium binding domain 
 As seen in Chapter 5 of this dissertation, N. gonorrhoeae PilC1 has one confirmed 
calcium binding site. However, there could be another potential calcium binding site at 
residue 516 consisting of DNDKPRDLGD (Figure 6.12). This putative binding domain is 
located outside of the C-terminal construct tested for calcium binding. Although not identical, 
this putative binding site has some characteristics of the DxDxDG calcium binding motif, the 
consensus 9 amino acid, and 12 amino acid calmodulin-like calcium binding domains 
[13,14]. A BLAST search revealed that this region is conserved in roughly 75% of the other 
GC PilC proteins, not always distinguishing between the PilC1 and PilC2. This search also 
revealed that many of the sequences had the 9 amino acid putative calcium binding domain, 
therefore lining up with the site at 700-709 in N. gonorrhoeae PilC1. The region is also not 
present in any of the PilCs in Neisseria meningitidis. With the current reagent of D709A full 
length N. gonorrhoeae PilC1, this hypothesis could be tested. As seen in PilY1 (Chapter 3), 
putative calcium binding domain could affect the adhesion mechanism itself. 
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6.5 Figure Legends 
 
Table 6.1 List of PilY1 protein constructs created. 
 
Figure 6.1 Dynamic light scattering of 532-1163 PAK PilY1. Peak 1 and 2 show that the 
sample was mono-dispersed with a value 11.8% (%pd<15%). 
 
Figure 6.2 Crystal hit of 532-1163 PilY1 in PEG II screen condition H6 (100mM Tris pH 8.5 
8% PEG 8000). Bar represents 100 microns. 
 
Figure 6.3 PilY1 protein degradation in crystal. A. SDS gel of 532-1163 Pak PilY1 crystals 
and protein from the entire over-nucleated drop. 
 
Figure 6.4 PilY1 binds manganese. Assay was performed as in Chapters 2, 3 and 4 with 
manganese being  
 
Figure 6.5 Infrared scan of a western blot showing IPTG induced PilY1 in whole cell PAK. 
Blot was scanned on an Odyssey Infrared Imaging System (LI-COR). PAK was grown in 
culture to O.D. =.6, lysed and diluted, and run on an SDS page gel. Gel was then transferred 
and stained with anti-PilY1 antibody. Secondary was infrared mouse anti-rabbit antibody. 
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Figure 6.6 Twitching and surface pilin expression in PAK. A. Twitching assays and B. pilus 
preps were performed as outlined in Chapter 2. 
 
Figure 6.7 Adhesion assay with PAK PilY1 RGD mutations. *represents p<.05. Values 
represented as % inoculum. Inoculum represents bacteria from the same stock that was 
added to wells, but directly to the agar plate instead. 
 
Figure 6.8 Small molecule inhibition of PilY1. A. Model of how the assay works with no 
inhibitor present. Fluorescence is inversely proportional to the concentration of PilY1. B. 
Model of how the assay works with the small molecule screen. The first panel shows what 
happens if the compound does nothing. The second panel shows if the molecule is a 
chelating compound or a compound that makes PilY1 bind more tightly to calcium. The third 
panel shows the theoretical result of a steric non chelating compound that blocks PilY1’s 
ability to bind calcium. 
 
Figure 6.9 PyMOL image of H797 interacting with the CBS of C-terminal PilY1 using the 
coloring found in Chapter 2 
 
Figure 6.1. Chromatograms and SDS Page gels of PAK PilY2. A. S75 Gel filtration profile 
and gel of purified PilY2. B. S200 Gel Filtration profile and gel of combined 532-1163 PilY1 
and PilY2 protein. 
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Figure 6.11 Circular dichroism wavelength scan of PilY2. Experiments were performed as in 
Chapters 2,3,4 and 5. 
 
Figure 6.12 Putative N. gonorrhoeae PilC1 calcium binding site. 
 
Table 6.1
Pa PilY1
Construct BL21  BL21 RIPL Origami 2
1 2‐614 ‐ ‐ ‐
2 31‐614 ‐ ‐ ‐
3 2‐491 ‐ ‐ ‐
4 31‐491 ‐ ‐ ‐
5 2‐326 ‐ ‐ ‐
6 31‐326 ‐ ‐ ‐
7 2‐292 ‐ ‐ ‐
8 31‐292 ‐ ‐ ‐
9 46‐287 ‐ ‐ ‐
10 46‐330 ‐ ‐ ‐
11 46‐489 ‐ ‐ ‐
12 46‐618 ‐ ‐ ‐
13 46‐1158 ‐ ‐ N/A
14 49‐321 ‐ ‐ ‐
15 49‐372 ‐ ‐ ‐
16 49‐598 ‐ ‐ ‐
17 127‐321 ‐ ‐ ‐
18 127‐372 ‐ ‐ ‐
19 127‐598 ‐ ‐ ‐
20 156‐321 ‐ ‐ ‐
21 156‐372 ‐ ‐ ‐
22 156‐598 ‐ ‐ ‐
23 49‐1158 ‐ ‐ N/A
24 127‐1158 ‐ ‐ N/A
25 156‐1158  ‐ SA N/A
26 354‐1163 ‐ + N/A
27 615‐1163  ++++ N/A N/A
28 532‐1163  ++++ N/A N/A
29 565‐1163 ++++ N/A N/A
30 565‐1097 ++++ N/A N/A
31 551‐1097 ++++ N/A N/A
32 551‐1163 ++++ N/A N/A
33 721‐1163 ++++ N/A N/A
34 726‐1163 ++++ N/A N/A
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Figure 6.1
Item R (nm) %Pd MW-R (kDa) %Int %Mass 
Peak 1 0.0 11.4 0 ---- ----
Peak 2 4.0 11.8 84 93.8 97.8
Peak 3 121.9 9.6 255876 3.6 0.0
Peak 4 28257.2 24.1 87484200000 2.6 2.2
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CHAPTER 7 
CONCLUSION 
 
7.1 Introduction 
Here, I attempt to convey the importance of looking at calcium binding sites in the 
PilC type IV pilus (tfp) family of proteins and formulate models in an attempt to show how 
PilC proteins regulate pilus biogenesis though calcium binding. I will also hypothesize how 
binding interactions between integrin with Pseudomonas aeruginosa PilY1 take place, and, 
explain other ways PilY1 could be mediating attachment to host integrins. 
 
7.2 Calcium Binding Site Homology 
P. aeruginosa PilY1, Kingella kingae PilC1/2, Neisseria gonorrhoeae PilC1/2, and 
Neisseria meningitidis PilC1/2 proteins all affect functional pilus biogenesis and function as 
adhesins (Chapter 2, 3, 4, 5, and personal communication with Dr. Joseph St. Geme III) 
[1,2,3,4,5,6,7,8,9]. Although it is has only been proven in P. aeruginosa PilY1, K. kingae 
PilC1, and N. gonorrhoeae PilC1 that a nine residue calcium binding site (CBS) controls 
functional tfp biogenesis, a BLAST search reveals well over 100 bacteria that all have the 
same conserved CBS in their respective PilC-like protein(s) including N. meningitidis, Xylella 
fastidiosa, and Ralstonia solanacearum, thus demonstrating that this site has a potentially 
wide  importance (Table 7.1) (Chapter 2, 5, and personal communication with Dr. Joseph St. 
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Geme III)  [3]. The majority of these CBSs occurred in the C-terminal domain of the protein 
as in P. aeruginosa PilY1 [3]. Studying these CBSs in PilC proteins from other organisms 
through processes such as structural determination, calcium binding assays, and pull-downs 
will continue to provide more information on host binding partners and the overall 
mechanism of tfp biogenesis, thus potentially leading to  the identification of therapeutic 
targets that if inhibited by small molecules could prevent initial bacterial attachment. 
  
7.3 Calcium Regulating Pilus Extension and Retraction 
How calcium is used in PilC proteins to regulate pilus extension and retraction 
remains unknown. The only structure for this family of proteins solved is the C-terminal P. 
aeruginosa PilY1, which shows a seven-bladed propeller and a sheet-loop-sheet CBS [3]. 
Knowing the physical location of the PilC proteins is crucial to understanding how calcium 
plays a role in pilus biogenesis. There are differing opinions on where PilY1 is located. 
However, the general consensus is that PilY1 resides in the bacterial outer membrane, 
pilus, or both [3,10]. Using antibodies against linear PilY1 epitopes, Bohn et. al. showed that 
PilY1 is present in bacterial cell membrane blebs, but not in the pilus; however in Orans et. 
al. upon sheared pilus preps, using an antibody for purified PilY1 C-terminal domain, PilY1 
appears in the pilus fraction [3,10]. Perhaps the antibody made to these epitopes was for 
inaccessible portions of the structured protein, and thereforw did not bind, thus, through 
electron microscopy, not visualized in the pilus [10]. This antibody production technique 
does not at all devalue the PilY1 that was seen in the membrane, it simply cast doubt on a 
conclusion based protein that was unseen. 
 Assuming that PilY1 is found in both the pilus and the membrane, one can begin to 
envision a mechanism on how calcium binding might mediate pilus extension and retraction. 
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In referencing only the PAK PilY1 851-859 CBS, one hypothesis is that the membrane 
bound PilY1 is the calcium unbound form and the pilus bound PilY1 is the calcium bound 
form, thus fitting with the model that when calcium is bound to this site, there is pilus 
extension, and when calcium is not bound, there is pilus retraction (Figure 7.1A) [3]. Note 
that there are many pili on the surface extending and retraction, hence in theory; there 
would always be PilY1 present on the membrane in the wild type organism (Figure 7.1A, B. 
For pilus extension to occur, the PilA subunit polymerization needs to overcome the 
retractionary force of PilT [11,12]. The calcium bound state of PilY1, via a subtle local 
structural change, could initiate attachment to the pilin-like protein cuff to oppose PilT 
mediated pilus retraction by acting as a notch in the pilus, preventing PilA 
retraction/depolymerization back through the PilQ pore protein (Figure 7.1A). When the 
calcium is pried away from this site by either a separate protein or more likely, a small steric 
change that makes binding calcium unfavorable in comparison to binding the pilin-like 
protein cuff, the notch in PilY1 is alleviated, thus allowing PilT mediated retraction to 
commence (Figure 7.1B). As the pilus is being retracted through PilQ, PilY1 is trafficked 
back into the membrane, ready to reinsert itself into the next pilus extension process (Figure 
7.1C, D). 
 
7.4 Calcium Affecting Integrin Binding 
Integrins are non-covalently linked heterodimeric cell adhesion and signaling 
receptors found in a variety of organisms from invertebrate to mammals [13]. The 
heterodimer of these surface proteins consists of an α-domain and a β-domain. Integrins are 
commonly found in the extracellular matrix and in tight junction regions between cells. 
Integrins, such as αVβ3 are known to have six metal (manganese or calcium) binding sites 
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in the apo structure and eight sites in the ligand bound structure with five metals bound in 
the α-domain of each respective structure [14,15]. None of these binding sites fit either the 
consensus calmodulin binding site or the nine residue site seen in PilY1. However, some 
sites do fit the consensus DxDxDG calcium binding motif [16]. Integrin metal binding is 
thought to be structural, however not much is known about the binding affinities of each site. 
One would have to make the low yield protein with calcium mimic mutations to each site 
except for one in question to determine the affinity of each respective site. Assuming each of 
the calcium mimics worked, even in the non-conventional metal binding sites, metal would 
need to be chelated out of the remaining site hoping the structural integrity stayed intact. 
This situation would also make it difficult to study how metal binding affinity would change in 
attached proteins. 
In Chapter 3, PilY1 was shown to binds integrin in an RGD- and calcium-dependent 
manner. It was also proposed that the 600-608 CBS in PilY1 could be interacting with an 
integrin consensus CBS to help chelate calcium in order to mediate better integrin binding. 
We know both CBSs play a role in integrin binding (Chapter 3). Surprisingly, the D859A 
mutation could overcome the detrimental D608A mutation. The forms of PilY1 that had 
calcium present or mimicked calcium at the 600-608 site could be responsible for an initial 
lower affinity integrin interaction that was not discernible by the assay used. However, the 
D859A mutation, specifically with calcium present or mimicked at the 600-608 site, leads to 
higher than wild type binding for PilY1. Accordingly, the moment of pilus attachment to a 
target (via PilY1 or some other protein) could act as a catch bond, therefore having a long 
range motions in the pilus; one effect being the elimination of calcium from the 851-859 site 
leading to pilus retraction thus leading to PilA depolymerization (Figure 7.2A, B). In 
reintegrating PilY1 back into the bacterial membrane, the target, in theory, would also stay 
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attached and thus, be in closer proximity to the bacterial cell, leading to higher avidity and 
ultimately a greater ability for the bacteria to infect (Figure 7.2C, D). 
 Another way in which calcium binding may be affecting integrin binding is controlling 
the interaction PilY1 might be having with itself.  Ligands using RGD bind in the integrin α- 
and β-subunit interface, mostly interacting with the residues phenylalanine-tyrosine-
tryptophan (FYW) [15]. PilY1 has a conserved phenylalanine-threonine-tryptophan (FTW) 
similar to FYW and is 13 residues upstream of the promixal 600-608 CBS in the PAK strain 
of P. aeruginosa (Figure 7.3). Although the match is not exact, the differing middle amino 
acids share a side chain –OH group. In the 600-608 calcium bound state of PilY1, the RGD 
could be sterically out of reach from the FTW located in PilY1 and therefore be available for 
binding to the integrin FYW. In the 600-608 non-calcium bound form of PilY1 the distance 
between RGD and FTW could be close enough to initiate binding, and therefore compete for 
integrin binding. Also, from what we have shown in Chapter 3, the 851-859 non-calcium 
bound form of PilY1 must be able to overcome this putative blocking on integrin binding. It 
should be noted that the FTW is also conserved in the PA14 strain, which has the RGD and 
putative CBS occur much earlier in the protein sequence. 
 
7.5 Other Putative Integrin Binding Mechanisms 
There are other potential mechanisms that explain why PilY1 binds to integrins. A 
BLAST search shows that PilY1 is homologous to proteins that have FG-GAP motifs, which 
are commonly found in seven bladed β-propellers [17]. These repeats have been found in 
both the α-integrin subunits and in ligands such as fibronectin and epidermal growth factor 
[17]. Many of these proteins have known CBSs which are homologous to the two found in 
PilY1 [17]. PilY1 has also been found to share the nine residue CBS homology and both N-
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terminal and C-terminal homology with the integrin binding protein von Willebrand factor 
type a [18]. Mimicking the fold and calcium binding site of an integrin binding ligand, or 
integrin itself, could provide PilY1 with yet another mechanism, besides the RGD, in which to 
bind integrin. 
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7.6 Figure Legends 
Table 7.1 Bacteria that have homologous calcium binding sites found in Orans et. al. Bolded 
bacteria were examined in this study. 
 
Figure 7.1 Model of calcium mediated pilus biogenesis. psPil represent pseudopilins. 
Proteins are not represented to scale, but for simplicity of the overall model. In reality, the 
ratio of pseudopilins to PilA is much lower [19]. (a) Model representing tfp extension where a 
small change in the represented PilY1 occurs in the non-calcium bound form as compared 
to the calcium bound form. (b) A small conformational change occurred in PilY1 (loss of the 
“notch”) leading to pilus depolymerization/retraction. (c) Tfp is retracting and PilY1 is being 
trafficked back into the membrane. (d) Tfp is fully retracted with calcium unbound PilY1 
located in the membrane. 
 
Figure 7.2 Model of calcium mediated pilus biogenesis based on target binding. Labeling 
and scale is consistent from figure 7.1. (a) Model representing tfp extension where a small 
change in the represented PilY1 occurs in the non-calcium bound form as compared to the 
calcium bound form. PilY1 is attached to RGD binding integrin. (b) A small conformational 
change occurs in PilY1 post binding leading to loss of the “notch” and thus pilus 
depolymerization/retraction. (c) Tfp is retracting and PilY1 is being trafficked back into the 
membrane with integrin still attached. (d) Tfp is fully retracted with calcium unbound PilY1 
located in the membrane with integrin attached 
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Figure 7.3 Alignment of PilY1 in various P. aeruginosa strains. FTW, 600-608 CBS and 
RGD are highlighted. Three varying strains of P. aeruginosa PilY1 were aligned using the 
biology workbench server [20,21]. Blue residues and an “*” corresponds to identical residues 
throughout the three strains, green residues and a “:” correspond to highly conserved 
residues, and navy residues and a “.” corresponds to mildly conserved residues (e.g. 
alanine and leucine).  Reference numbers are for PAK_287 PilY1 (the strain used in this 
study). 
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Acidovorax delafieldii
Acinetobacter baumannii 
Acinetobacter calcoaceticus
Acinetobacter haemolyticus
Acinetobacter lwoffii
Acinetobacter radioresistens 
Aeromonas caviae
Aeromonas hydrophila
Aeromonas salmonicida
Aeromonas veronii
Alcanivorax borkumensis
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Alteromonadales bacterium
Alteromonas macleodii 
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Cardiobacterium hominis
Chromobacterium violaceum
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Cupriavidus necator
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Kingella oralis 
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Marichromatium purpuratum
Marinobacter adhaerens
Marinobacter aquaeolei
Methylobacter tundripaludum
Methylococcus capsulatus
Methylomonas methanica
Methylophaga aminisulfidivorans
Methyloversatilis universalis
Moritella sp.
Myxococcus xanthus
Neisseria bacilliformis 
Neisseria cinerea
Neisseria elongata
Neisseria flavescens 
Neisseria gonorrhoeae 
Neisseria lactamica
Neisseria macacae
Neisseria meningitidis 
Neisseria polysaccharea
Neisseria sicca
Neisseria subflav
Neisseria weaveri 
Nitrococcus mobilis
Nitrosococcus halophilus
Nitrosococcus oceani
Nitrosococcus watsonii 
Nitrosomonas europaea
Oceanobacter sp.
Oceanospirillum sp.
Oxalobacteraceae bacterium 
Pelobacter carbinolicus
Persephonella marina
Polaromonas naphthalenivorans
Populus trichocarpa
Pseudoalteromonas atlantica
Pseudoalteromonas haloplanktis
Pseudoalteromonas tunicata
Pseudogulbenkiania sp.
Pseudomonas aeruginosa 
Pseudomonas fulva
Pseudomonas mendocina
Pseudomonas stutzeri
Psychrobacter arcticus
Psychromonas sp. 
Ralstonia eutropha
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